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ABSTRACT 
This thesis describes the development and optical characterization of near infrared (NIR) gold 
nanoshells for the use as luminescent contrast agents for applications in small animal blood vessel 
imaging. Two types of gold-silica nanoshells excitable by NIR lasers are investigated: Type 1 
nanoshells can be excited with a sub-|xm NIR laser, whereas Type 2 nanoshells can be excited 
with a NIR laser in the micrometer range. Using NIR microscopy as an imaging platform, ex vivo 
and in vivo experiments are conducted to determine the efficacy of these nanoshells as suitable 
contrast agents. Specifically, individual particles of Type 1 nanoshells are successfully imaged 
and shown to provide bright optical contrast for blood vessel imaging both ex vivo and in vivo, 
while the Type 2 nanoshells are clearly imaged within the blood vessels ex vivo. These positive 
results suggest a promising possibility of developing a new class of contrast agents for deep tissue 
imaging and improving the imaging depth of NIR imaging techniques. 
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1. Introduction 
1.1. Introduction 
Metal nanoshells are a class of nanoparticles that consist of a spherical dielectric core with a thin 
metallic shell. They were first engineered by the Halas Laboratory at Rice University in 1998 
(Oldenburg, Averitt et al. 1998). They have been used as fluorescent diagnostic labels (Makarova, 
Ostafin et al. 2006), substrates for surface-enhanced Raman scattering (SERS) (Jackson and 
Halas 2004), and fluorescence enhancers (Bardhan, Grady et al. 2008). Among various types of 
metal nanoshells, gold coated nanoshells are widely used in biomedical applications because they 
are biocompatible (Connor, Mwamuka et al. 2005; Loo, Lowery et al. 2005) and their optical 
resonance can be tuned to the near infrared (NIR) region (Oldenburg, Averitt et al. 1998). More 
specifically, when the optical resonance is tuned to the NIR, nanoshells can act as NIR absorbers 
for thermally controlled drug delivery (Sershen, Westcott et al. 2000) and in vivo cancer therapy 
(Hirsch, Stafford et al. 2003). In additon to being used as a photothermal converter, nanoshells 
are used for combined imaging and therapy because their optical resonance can be tuned to 
simultaneously provide scattering and absorption. These special scattering and photothermal 
properties of nanoshells have been exploited to provide optical contrast in aplications, such as 
optical coherence tomography (OCT) imaging and photo thermal therapy (Gobin, Lee et al. 2007). 
Other than the basic absorption and scattering properties of nanoshells, the luminescent 
properties of nanoshells have gained increasing interest from the viewpoint of induced 
luminescent contrast (Park, Estrada et al. 2008). In addition to the luminescent contrast, the 
luminescent properties of nanoshells can be integrated with cancer therapy and optical imaging 
using two-photon excitation microscopy in vitro (Loo, Lowery et al. 2005; Bickford, Sun et al. 
2008). In an effort to study the luminescent properties of nanoshells and their subsequent utility 
for in vivo luminescent imaging in live tissue or organisms, this thesis emphasizes the 
development and quantitative analysis of biocompatible nanoshells that are capable of producing 
usable optical contrast for in vivo imaging. In this thesis, two types of gold-silica nanoshells 
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excitable by NIR lasers are specifically analyzed: Type 1 nanoshells can be excited with a sub-
orn NIR laser, whereas Type 2 nanoshells can be excited with a NIR laser in the micrometer 
range. Ex vivo and in vivo experiments were conducted to determine the efficacy of these 
nanoshells as suitable contrast agents. Specifically, individual particles of Type 1 nanoshells were 
successfully imaged and shown to provide brighter optical contrast for blood vessel imaging both 
ex vivo and in vivo while the Type 2 nanoshells were clearly imaged within the blood vessels ex 
vivo after intravenous injection. These positive results of nanoshell contrast suggest a promising 
possibility of developing of a new class of contrast agents for deep tissue imaging and providing a 
higher resolution imaging strategy for combined detection and treatment. Additionally, these 
results demonstrate the potential of tuning gold nanoshells for a wide range of excitation 
wavelengths since they can be engineered for excitation with both sub-^m and micrometer-level 
lasers. Nanoshells excitable with NIR lasers on the micrometer-level, in particular, has an 
important significance for deep tissue imaging. Micrometer-level NIR lasers are believed to have 
extended penetration depth with less scattering, but currently available contrast agents are mostly 
excited with sub-jim wavelengths. The development of bright and tunable contrast agents 
excitable with NIR wavelengths over l^m can be utilized in the micrometer-level NIR region and 
can, as a result, extend imaging depth by having low absorption as well as low scattering from 
tissue. Therefore, the positive research result reported in this thesis may provide important 
information with regard to the design of NIR nanoshells and serve as a foundation for the future 
optimization of nanoshell tuning and luminescence-based contrast techniques compatible with 
deep tissue imaging. 
1.2. Synthesis and Optical Properties of Nanoshells 
1.2.1. Synthesis of Gold-Silica Nanoshells 
The fabrication technique for nanoshells includes molecular self-assembly and colloid chemistry 
of metal colloid synthesis (Oldenburg, Averitt et al. 1998; Westcott, Jackson et al. 2002). Silica 
cores, which situate in the center of nanoshells, are made with the Stober method, which involves 
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the reduction of tetraethylorthosilicate (TEOS, Aldrich) in ethanol. In the next step, 
aminopropyltriethoxysilane (APTES, Aldrich) molecules are absorbed on these Stober particles, 
resulting in silica cores with outwardly attached amine groups as the new surface. When these 
functionalized groups are placed in a gold colloidal solution, small gold colloids bond covalently 
to the amine group. These small gold colloids (1-3 nm) are fabricated according to the method of 
Duff and Baiker (Duff, Baiker et al. 1993). Gold colloids provide the nucleation sites for further 
growth and coalescence of gold colloids onto the nanoparticle surface until a complete shell is 
formed (Figure 1.1). The amount of gold added during this final reduction stage determines the 
shell thickness. A schematic drawing of this process is shown in Figure 1.2 
Figure 1.1: Schematic of forming core-shell structure - taken from (Lee 2006): silica cores with 
attached amine groups outward as outer terminal for coalescence of gold colloid. 
Figure 1.2: Schematic of nanoshell fabrication process - taken from (Halas 2002). Gold colloid 
provides the nucleation sites for further growth and coalescence of gold colloid on silica 
nanoparticle surface. 
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1.2.2. Optical Properties of Nanoshells 
Upon interaction with light, metal particles are polarized. Driven by the electrical field of the 
light, their band electrons oscillate. An optical plasmon resonance occurs due to collective 
oscillation of the band electrons (Averitt, Westcott et al. 1999), corresponding to the maximum 
polarization of the metal particles. The interaction of metal nanoshells with light can be explained 
by the classical Mie scattering theory (Mie 1908). Mie formulation involves solving Maxwell's 
equations with the appropriate boundary conditions in spherical coordinates, yielding a solution 
in the form of a series expansion of vector eigenfiictions (Sarkar and Halas 1997). The optical 
properties are often expressed in terms of the absorption, the scattering, and the extinction cross 
sections: a abs, <J sea, & ext (Bohren and Nevitt 1983). Equations 1.1 and 1.2 illustrate the Mie 
solution of extinction and scattering cross sections using series expansions (Bohren and Huffman 
1983). 
Equation 1.1 
n=1 
Equation 1.2 
|a:| i 
In these equations, k is the wave number (2n/X), and an and bn are the series expansion 
coefficients, which are related to the circumference of the particles and to the ratio of the 
refractive index of the nanoshells to that of the surrounding medium. The total extinction cross 
section is given by Equation 1.3 
Equation 1.3 
aext =a,sca +<Jabs 
Figure 1.3 shows a schematic diagram of nanoshell parameters used in the calculation of 
Mie theory. Si, e2, and e3 refer to the dielectric functions of the core, shell, and embedding media 
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respectively, and rj and r2 refer to the radius of the core and that of the overall particle, 
respectively. 
Figure 1.3: Nanoshell parameters used for the calculation of Mie theory. 
Based on Mie theory, the polarization ( a ) of the band electrons is calculated using 
Equation 1.4. Plasmon resonances occur at the point of maximum polarizability, when the 
denominator approaches zero (Averitt, Sarkar et al. 1997; Averitt, Westcott et al. 1999). 
Equation 1.4 
a = s (g2 ~ g3 )(gt + 2s2 ) + (rt / f 2 ) 3 ( g i ~ g2 )(g3 + 2si) ^ 
0 (e2 + 2s3)(£, +2s2) + (r, /r2)3(ex -s2)(2s2 -s3) 
Averitt et al. later employed the quasi-static approach in this calculation and simplified 
the results. Quasi-static limit is reached when the diameter of the particles is much smaller than 
the wavelength of the incident light (Sarkar and Halas 1997). The electromagnetic field of 
incident light is assumed to be spatially constant while its temporal variations are preserved 
(Averitt, Westcott et al. 1999). In this paper, quasi-static calculations were shown to match well 
with the results from Mie scattering calculations, validating the usefulness of this approach in the 
calculation of the optical effect of nanoshells. Thus, the calculations for scattering cross section 
(<7sca), absorption cross section (<Jabs), and polarization ( a ) are simplified as in Equations 1.5, 
1.6, and 1.7, respectively. 
Equation 1.5 
125?r V r , 6 
3 z s 2 e a £^£b 
3 A4 S2Sa + 
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Equation 1.6 
8 i f f e r l r 
°abs = y 1 Im 
£2£a g 3 £b 
\£l£a + 2£3£b j 
Equation 1.7 
a = 4 ns ar2 
£ l £ a £3£b 
s2sa + 2s3 sb)_ 
To further characterize the polarization of band electrons, the wavelength of the incident 
light X required for plasmon resonance is used as a variable in the calculation. This wavelength 
is shown to be related to the ratio of the radii of the core and the shell given by Equation 1.8 
Equation 1.8 
1 + 3 £2{x\sx+2S,) 1 ZL 
h 
3 / 
2 [£2^)l + £l) + " f e W f l 
Equation 1.8 demonstrates that the plasmon resonance can be tuned by varying the shell 
thickness scaled by the size of the particles. Based on this calculation, Oldenburg et al. 
demonstrated the feasibility of engineering composite nanoparticles with controlled plasmon 
resonance (Oldenburg, Averitt et al. 1998). 
1.3. Tunability of Nanoshells in the NIR Optical Window 
The main reason that gold nanoshells have attracted major research attention for various 
biomedical applications is that their plasmon resonance can be fine tuned by varying the thickness 
of the gold shell scaled by the particle size from the visible into the NIR spectrum (Figure 1.4) 
(Jain and El-Sayed 2007), which is a region of highest physiological transmissivity (Oldenburg, 
Jackson et al. 1999). In most biological tissues, absorption and scattering of light are the major 
factors limiting the penetration depth. The NIR region, especially from 600 nm to 1200 nm, is 
considered highly attractive for imaging because this region of the spectrum is characterized by 
low absorption and high transmissivity by native chromophores in the tissue, such as proteins and 
other organic molecules (Boulnois 1986). Figure 1.5 shows the absorption spectrum of some 
common native molecules, among which haematoporphyrin derivative (HPD) and haemoglobin 
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(Hb02), commonly present in vascularized tissue, absorb in the visible bands up to 600 nm. The 
absorption spectrum of melanin, the most prevalent epidermal chromophore, is distributed mainly 
in the UV and visible regions. On the other hand, infrared (IR) radiation is absorbed by water 
with an increasing trend towards longer wavelengths. By comparison, tissue is relatively 
'transparent' between 600 nm and 1200nm (Parrish 1981) because of the lack of chromophores 
strongly absorbing at these wavelengths. 
Because of the absence of strong chromophoric absorption, tissue absorption is 
considered negligible compared to scattering when imaged in the NIR region. The extent of 
scattering is described by the 'mean free path (ls)', which is the average distance between 
scattering events. The mean free path increases with longer wavelengths, resulting in reduced 
scattering (Helmchen and Denk 2005); therefore higher imaging depths can be achieved by using 
a light source of NIR compared to a visible light source. To take advantage of this NIR optical 
window, many contrasts agents, such as fluorescent proteins and Dextrans, have been developed 
to assist imaging in this particular region. However, the currently available contrast agents often 
have the limitations, such as low photostability (Frangioni 2003), low brightness (Frangioni 2003; 
Shaner, Campbell et al. 2004) or cytotoxicity (Hardman 2006). By comparison, gold nanoshells 
have been shown to be biocompatible (Hirsch, Gobin et al. 2006) and to possess a much brighter 
luminescence than common luminescent contrast agents (Park, Estrada et al. 2008). In addition to 
the biocompatibility and high luminescence level of nanoshells, the plasmon resonance of 
nanoshells can be tuned to the NIR region as previously discussed. Therefore, nanoshells is a 
desirable contrast agent candidate that is specifically suitable for deep tissue imaging. The tuning 
flexibility of nanoshells also enables the possibility of micrometer-level NIR imaging at spectrum 
over 1 nm (1000-1200 nm), at which region the imaging depth can be further extended because 
micrometer-level lasers scatter to a lesser degree than sub-jam lasers, and result in reduced 
intrinsic scattering in tissue. To verify the aforementioned hypothesis and analyze the 
characteristics of NIR nanoshells for the application of real-time and functional luminescent 
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imaging, nanoshells excited with both sub-jam and above lfim 
animal models, providing important information for future 
nanoshells as contrast agents for deep tissue imaging. 
lasers are developed and studied in 
development and optimization of 
60 nm core radius 
20 nm shell 
Increasing 
60 nm core radius 
5 nm shell 
1200 
Wavelength (nm) 
Figure 1.4: Theoretically calculated tunability of optical resonance from nanoshells - adapted 
from (Gobin 2007). Nanoshells with the same 120 nm core and different diameters show a 
shift of extinction wavelength over 400 nm from visible into the NIR. 
10 8 6 5 4 3 0.6 06 0.5 0.4 0.3 0.2 
300 400 300 70Q 1000 2000 3000 4000 5 000 7 000 10000 Mnm) 
Figure 1.5: Spectrum of absorption coefficient for water, haemoglobin (Hb02), melanin and 
haematoporphyrin derivative (HPD) - taken from (Boulnois 1986). 
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1.4. Biomedical Applications of Metal Nanoshells 
1.4.1. Optically-Responsive Drug Delivery System 
One of the earliest applications of gold nanoshells was their use as NIR absorbers in an optically-
responsive drug delivery system (Sershen, Westcott et al. 2000). Composite hydrogels were made 
from NIR absorbing gold-silica nanoshells and thermal-responsive polymers, specifically, poly-
N-isopropylacrylamide (NIPAAm)-co-acrylamide (AAm). NIPAAm has a lower critical solution 
temperature (LCST) (Hirsch, Gobin et al. 2006). LCST is the temperature above which the 
hydrogels will undergo a drastic phase change and collapse in size (Figure 1.6). Sershen et al. 
have shown that the NIR excited nanoshells were able to provide enough heat for NIPAA 
hydrogels to exceed LCST. Proteins within the hydrogels were then released because of the 
expulsion of water and structural changes of the polymer chains (Sershen, Westcott et al. 2000). 
Figure 1.7 illustrates the pulsatile release of proteins from nanoshells containing NIPAAm-co-
AAm hydrogels by exposure to a pulsatile NIR laser, thereby illustrating the system's controlled 
drug release capability. 
— 
C m J ^Swollen 
2 —EE 
3 — | 
( ^ > Collapsed 
Figure 1.6: Nanoshells within the NIPAA hydrogels are NIR absorbers, driving the phase change of the 
polymer and leading to the release of the proteins loaded within the hydrogels. - taken from (Hirsch, 
Gobin et al. 2006) 
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Figure 1.7: Multiple burst release of trapped proteins with the NIPPA hydrogels corresponding 
to the NIR radiation - taken from (Hirsch, Gobin et al. 2006). 
In addition to being NIR absorbers and inducing phase change of the bio-materials, gold 
nanoshells have also been used as NIR-responsive siRNA carriers in drug delivery system. Braun 
et al. have recently reported NIR-medicated release of siRNA from coated 40 nm gold nanoshells 
(Braun, Pallaoro et al. 2009). In this model, 40 nm hollow gold nanoshells were used as NIR 
absorbers. siRNA was linked to the surface of the gold nanoshells, and released through surface-
linker bond cleavage upon exposure to a pulsed NIR laser (Braun, Pallaoro et al. 2009). The 
system was validated in a cell culture system as an effective temporally and spatially controlled 
siRNA cellular delivery system for gene silencing. 
1.4.2. Nanoshells for Diagnostics 
An immunoassay is a chemical test used to detect the presence or concentration of a substance 
within a complex solution. This specificity is achieved by using specific antibody-antigen 
interactions. Conventional immunoassays, such as enzyme linked immunosorbent assay (ELISA), 
which is the most widely used immunoassay for disease detection, all have some limitations. To 
detect an antigen in a blood sample, multiple preparation steps are needed before detection, which 
lengthen the processing time (4-24 h) (Hirsch, Gobin et al. 2006). Hirsch et al. demonstrated a 
fast immunoassay using antibody-conjugated gold-silica nanoshells to detect analytes within 
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whole blood (Hirsch, Jackson et al. 2003). The system was designed by surface coating 
nanoshells with antibodies: when antibody-conjugated nanoshells were exposed to an analyte-
containing mixture, the nanoshells aggregated by binding to the analytes (Figure 1.8). The 
aggregation led to a red-shift of plasmon resonance, which could be detected without separating 
nanoshells from the mixture (Hirsch, Jackson et al. 2003). This method detected antigens in 
samples containing up to 20% blood over the range of 88-0.8 ng/mL within 10-30 minutes 
(Hirsch, Jackson et al. 2003). It significantly reduces the detection time and simplifies the 
diagnostic process, yet has a sensitivity similar to that of ELISA (Hirsch, Gobin et al. 2006). 
600 700 800 
Wavelength (nm) 
Figure 1.8; Detection of analytes using nanoshells immunoassay - taken from (Hirsch, Jackson 
et al. 2003). Solid line shows the extinction spectrum of nanoshells in the absence of the analyte, 
with a peak in the NIR. In the presence of the analyte, the interaction of antibody-antigen causes 
nanoshells to aggregate, inducing the reduction and red-shift of the original peak of extinction. 
1.4.3. Nanoshells for Cancer Therapy 
One of the most important biomedical applications of gold nanoshells is their use in cancer 
therapy. Metal nanoshells possess the ability to absorb light and convert it to heat in a much more 
efficient way than the conventional dyes (O'Neal, Hirsch et al. 2004). They possess larger 
absorption cross sections as much as six orders of magnitude than indocyanine green (ICG), 
which is an FDA-approved NIR dye for clinical use (Landsman, Kwant et al. 1976; O'Neal, 
Hirsch et al. 2004). Hirsch et al. showed localized and irreversible photothermal ablation of tumor 
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cells both in vitro and in vivo using gold-silica nanoshells (Hirsch, Stafford et al. 2003). The 
nanoshells used were coated with poly(ethylene glycol) (PEG) using a molecular self-assembly 
technique (Hirsch, Jackson et al. 2003) to improve compatibility and avoid premature removal of 
the nanoshells from circulation. It has been demonstrated that PEGylated molecules and some 
biomaterials, such as drug-delivering liposome, manifest suppressed immune response and 
improved circulation time (Delgado, Francis et al. 1992; Chen and Scott 2001; Harris, Martin et 
al. 2001; Maruyama 2002). In the in vivo experiment by Hirsch et al., PEGylated nanoshells were 
injected into the tumor volume. At forty minutes post-injection, the tumor sites were exposed to a 
NIR laser for 4-6 minutes with wavelength at the plasmon resonance of the nanoshells. The laser 
power was controlled at 10 to 25-fold less than that previously used for testing the photothermal 
effects of ICG dye (Chen, Adams et al. 1996; Hirsch, Stafford et al. 2003). The temperature 
profile was monitored by a phase-sensitive fast spoiled gradient-echo MRI (Hirsch, Stafford et al. 
2003). Figure 1.9 shows the average tumor heating effects in the nanoshell-treated animals 
compared to the control animals receiving PBS injection. Figure 1.10 further shows the 
temperature profile as a function of depth. In this experiment, the tumor tissue showed an average 
temperature increase of 37.4±6.6 °C, causing irreversible damage to the tumor. 
AT±$D 
Mouse Control Nanoshell 
2 
3 
4 
5 
6 
4.7 ± 0.7 
8.4 ± 1.6 
9.1 ± 2.5 
5.9 ± t.2 
8.7 ± 0.9 
7.6 ± 1.6 
39.7 ± 4.7 
60.4 ± 3.4 
44.6 ± 6.0 
32.8 ± 1.2 
28.1 ± 1.0 
32.5 ± 0.7 
Figure 1.9: Average heating effects introduced by photothermal therapy using nanoshells -
taken from (Hirsch, Stafford et al. 2003). 
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Figure 1.10: Temperature measurement in nanoshell photothermal therapy in terms of depth -
taken from (Hirsch, Stafford et al. 2003). 
In addition to this study, O'Neal et al. further showed nanoshell photothermal treatment 
using systemic delivery rather than intra-tumor delivery. The nanoshells were injected and 
preferentially accumulated in the growing tumors (Hashizume, Baluk et al. 2000). The leakiness 
of blood vessels is a passive mechanism called the 'enhanced permeability and retention (EPR)' 
effect (Maeda 2001; Maeda, Sawa et al. 2001). The hyperpermeability of tumor associated 
vessels is a property of tumor-induced angiogenesis, which likely leads to the production of 
unstable endothelial cell interactions or smooth muscle cell associations (McDonald and Baluk 
2002; Fukumura and Jain 2007; Weis 2008) and thus allows for easy extravasation of 
nanoparticles into the tumor tissue (O'Neal, Hirsch et al. 2004). In their study, nanoshells were 
intravenously injected, and tumor tissue was illuminated with a NIR laser 6 hours after injection. 
All of the treated mice were tumor free for more than 90 days, while the control animals showed 
significant tumor growth to predetermined size limit and were euthanized within 20 days after 
treatment (O'Neal, Hirsch et al. 2004). These research results have shown the great promise of 
gold nanoshells for cancer therapy. Most significantly, neither the nanoshells nor the NIR laser 
appears to be toxic to the tissue when used alone. However, when combined, they can effectively 
generate localized heating to the tumor tissue and increase the survival rate of the organism. 
1 2 3 . 4 5 
Depth from skin (mm) 
6 min 1 0 
3 min 
1 mm 
0 min 1 2 3 4 5 
Depth from skin (nun) 
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1.4.4. Combined Imaging and Therapy 
1.4.4.1. Scattering-based Imaging 
Given the success of developing nanoshells for cancer treatment using passive-accumulation in 
vivo, much research focus has shifted to developing nanoshells for combined diagnosis and 
therapy (Ferrari 2005). In the field of cancer therapy, antibody-coated nanoparticles have been 
shown to target tumor cells in vitro (Park, Kirpotin et al. 2001; Farokhzad, Jon et al. 2004) and 
destroy them upon exposure to the NIR laser (Lowery, Gobin et al. 2006). The scattering property 
of nanoshells has been exploited to develop combined targeting, imaging and therapy. According 
to the Rayleigh criteria, the scattering property of particles smaller than the wavelength of light is 
proportional to R6 (van Dijk, Tchebotareva et al. 2006), while their absorption is proportional to 
R3 (Hu, Fleming et al. 2008) (R is the radii of the particles). Therefore, scattering decreases faster 
than absorption when particle size decreases, allowing the scattering-absorption ratio of the 
nanoshells to be tuned (Figure 1.11). The nanoshells with balanced scattering and absorption can 
thus have dual diagnostic and therapeutic applications. Loo et al. have demonstrated a nanoshell-
based in vitro platform technology for a combined imaging and cancer treatment application 
(Loo, Lowery et al. 2005). Figure 1.12 shows that HER2 (human epidermal growth factor 
receptor 2)-expressing cancer cells were imaged and photo-ablated with antibody-conjugated 
nanoshells using their scattering and absorption properties separately. In an in vivo study, Gobin 
et al. showed dramatic contrast increase for scattering-based optical coherence tomography 
(OCT) and effective photothermal therapy of tumor (Gobin, Lee et al. 2007). In their model, 
nanoshells were designed to have approximately 67% of extinction from absorption, and 33% 
from scattering. After being introduced intravenously into the mice, nanoshells were shown to 
provide enhanced contrast for in vivo OCT imaging of the tumor tissue (Figure 1.13, Figure 1.14). 
Following the OCT imaging, animals were exposed to a NIR laser and a reduced tumor size 
together with significantly increased survival rate were reported by day 21 (Gobin, Lee et al. 
2007). The above experimental documentation strongly suggests that scattering properties of 
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nanoshells may be used together with their NIR absorption for combined imaging and therapeutic 
applications. 
Total Diameter, [nm] 
- • = % Extinction due to Scattering ' -C= % Extinction due to Absorption 
Figure 1.11: Changes of scattering and absorption properties of gold nanoshells with different 
particle sizes - taken from (Gobin 2007). This simulation is preformed using gold-silica nanoshells 
with the same core-shell ratio. It shows that smaller nanoshells are absorbance-dominant and bigger 
nanoshells are scattering-dominant. 
Figure 1.12: Combined imaging and therapy of cancer cells using nanoshells conjugated with anti-
HER2 antibodies - taken from (Loo, Lowery et al. 2005). Darkfield images of HER2 expression 
were acquired using scattering from nanoshells. Middle panels showed the cell viability staining 
using calcein. Silver stains served as control to detect the presence of nanoshells. Photothermal 
ablation was only observed from cells treated with HER2-targeted nanoshells and a NIR laser. 
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Figure 1.13: OCT imaging of tumor tissue from nanoshell-treated mice and control mice - taken 
from (Gobin, Lee et al. 2007). A significant increase in contrast was observed from tumor tissue of 
the mice receiving nanoshell treatment, while no increase was observed in the normal tissue. 
Figure 1.14: Quantification of OCT contrast enhancement from nanoshell injection - taken from 
(Gobin, Lee et al. 2007). Normal tissue is shown in brown bar, and tumor tissue is shown in 
black bar. 
1.4.4.2. Luminescence-based Imaging 
In addition to the scattering-based imaging, nanoshells have been increasingly investigated for the 
luminescence-based imaging. Before gold nanoshells, gold nanorods were reported as 
luminescent contrast agents for small animal imaging both in vitro and in vivo (Wang, Huff et al. 
2005). In their study, gold nanorods were excited using 830 nm wavelength with a two-photon 
excitation microscope. Luminescent signal from a single nanorod was shown to be 58 times 
brighter than that of a single rhodamine molecule. Using these nanoparticles as NIR contrast 
2.5 
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agents, in vitro and in vivo imaging were also demonstrated (Wang, Huff et al. 2005). Similarly, 
luminescent gold nanoshells were applied in vitro (Bickford, Sun et al. 2008) and in vivo (Park, 
Estrada et al. 2008) for imaging applications. Figure 1.15 shows the luminescent imaging of live 
breast cancer cells with immunotargeted nanoshells (Bickford, Sun et al. 2008), in which anti-
HER2-conjugated nanoshells were used to target cancer cells. Different imaging channels were 
used at the same time to examine the emission from 451 - 644 nm. Cancer cells labeled with 
nanoshells showed enhanced contrast from unlabeled cancer cells, as well as labeled and 
unlabeled normal cells (Bickford, Sun et al. 2008). In addition, Park et al. showed an in vivo 3-D 
distribution of gold nanoshells targeted to murine tumors (Figure 1.16). In the study of Park et al., 
nanoshells were introduced intravenously and imaged by a custom-built multiphoton microscope. 
It was shown that gold nanoshells possess the same intensity of luminescence as fluorescent 
beads while fluorescent beads require 12 times higher laser power. Furthermore, nanoshells have 
been reported to produce 140 times brighter signal than fluorescent beads with the same incident 
power (Park, Estrada et al. 2008). Thus, the luminescence property of gold nanoshells has great 
potential for combined diagnosis and cancer therapy. Given the extraordinary brightness of these 
particles, nanoshells also possess the potential to be used as NIR contrast agents for high-
resolution small animal imaging applications. 
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451-483 nm 483-515 nm 515-547 nm 558-579 nm 590-644 nm 
Figure 1.15: Multi-spectral imaging of cancer cells and normal cells - taken from (Bickford, Sun et al. 
2008). (a) Nanoshell-labeled imaging of cancer cells at 10% laser power, (b) Unlabeled cancer cells 
imaging at 100% laser power. Emission signal comes from autofluorescence produced by the cells, (c) 
Imaging of nanoshell-labeled normal cells at 10% laser power, (b) Imaging of unlabeled normal cells at 
100% laser power. Panels B, C and D serve as control. 
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Figure 1.16: White light and luminescence imaging from subcutaneous tumors. - taken from 
(Park, Estrada et al. 2008). (a)(b) White light and luminescence imaging of tumor after injection 
of nanoshells. (c)(d) White light and luminescence imaging of tumor without injection of 
nanoshells. 135 nm diameter nanoshells were used for intravenous injection. Nanoshells were 
imaged with a 780 nm wavelength laser. A 610 nm short pass emission filter was used to 
collect the luminescence and block the scattered excitation light. 
1.4.4.3. Other Imaging Techniques 
Besides scattering- and luminescence-based imaging techniques, nanoshells have also been 
studied using other platforms. Kim et al. designed multifunctional magnetic nanoshells, and 
showed their application for combined magnetic resonance (MIR) imaging and photothermal 
therapy in vivo (Kim, Park et al. 2006). Nanoshells have also been shown to enhance contrast 
between vessels and brain tissue detected with photoacoustic tomography (PAT) (Wang, Xie et 
al. 2004). In vitro analyses have demonstrated contrast enhancement by absorption of nanoshells 
using optoacoustic imaging (Fournelle, Maass et al. 2007). 
1.5. Conclusions 
Gold nanoshells have gained intense research interests because of their strong plasmon resonance 
as well as flexible tunability in the optically transparent NIR window. They can be tuned to 
absorb light in the NIR region, efficiently transfer the photonic energy into heat, and thus enable 
their broad application in drug delivery, diagnosis and cancer therapy. On the other hand, 
nanoshells have shown a broad application in optical imaging. In particular, the luminescence of 
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nanoshells has been demonstrated to be much brighter than contrast agents of comparable size 
(Park, Estrada et al. 2008), thus providing a significant opportunity to extend the imaging depth 
for NIR imaging techniques. The studies in this thesis further exploit the luminescence property 
of nanoshells and their subsequent utility for imaging. Two-photon excitation microscopy is used 
as a high-resolution NIR imaging platform to optically characterize nanoshells both ex vivo and in 
vivo. Single particles are identified in the experiments, providing contrast for blood vessel in vivo 
imaging. In order to further test the potential of nanoshells in improving the imaging depth, 
another type of nanoshells is engineered for micrometer-level NIR excitation. Micrometer-level 
NIR laser scatters to a lesser degree and penetrates deeper than the normally used sub-|xm NIR 
laser source for two-photon microscopy. Taking advantage of the micrometer-level NIR 
excitation laser and the tunability of nanoshells in the similar spectral region, this thesis 
successfully demonstrated the feasibility of using nanoshells as contrast agents for luminescent 
imaging with sub-cellular resolution in a wide range of excitation wavelengths. Their superior 
brightness and their capability for excitation with NIR laser on the micrometer-level are merits 
leading to the promise of extending depth of NIR imaging techniques. 
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2. Two-Photon Laser-Scanning Microscopy (TPLSM) 
2.1. Introduction 
Since the introduction of confocal imaging, two-photon excitation microscopy (Denk, Strickler et 
al. 1990) presents an important advancement in optical microscopy for biomedical research. 
Although imaging techniques, such as OCT, MRI, computed tomography (CT), positron emission 
tomography (PET) and ultrasonography can provide noninvasive, functionally relevant images on 
animal models, only confocal microscopy and multiphoton microscopy methods are capable of in 
vivo imaging with submicron resolution (Amos 2000; Hell 2003; McDonald and Choyke 2003). 
Especially in recent decades the development of fluorescent probes has provided excellent 
detection senstivity at the single-cell resolution (Arndt-Jovin, Robert-Nicoud et al. 1985; Tsien 
1998; Zhang, Campbell et al. 2002). In addition, three-dimensional imaging (3D) of cellular 
structure has been aided by the excellent optical sectioning capability of the confocal and 
multiphoton optical method (Webb 1996; Masters and Bohnke 2002; Amos and White 2003; 
Periasamy and Diaspro 2003). For deeper tissue imaging (300-500 (am), two-photon laser 
scanning microscopy (TPLSM) has been increasingly preferred over single-photon confocal 
microscopy, especially when cellular or subcellular resolution is required (Helmchen and Denk 
2005; Lichtman and Conchello 2005). This is because NIR photons are absorbed and scattered to 
a lesser degree than visible light, enabling deep penetration into dense tissues (Helmchen and 
Denk 2005). Two-photon excitation is a non-linear process, utilizing NIR light and producing 
excitation only at the focal plane (Lichtman and Conchello 2005) (Figure 2.1). Photobleaching 
and phototoxicity are also reduced because NIR is less destructive to live cells (Patterson and 
Piston 2000; Mondal and Diaspro 2007). In addition, ultra-fast pulsed laser sources (Curley, 
Ferguson et al. 1992; Wokosin, Centonze et al. 1997) are used in order to increase excitation 
probability while maintaining a relatively low average power because high power lasers are 
destructive to the tissue. These remarkable advantages have made two-photon microscopy a 
popular tool for the in vivo observation of cells within scattering tissues (Helmchen and Denk 
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2005; Lichtman and Conchello 2005), and it has been used to quantify stem cell markers (Rice, 
Kaplan et al. 2007) and study fibroblast migration in vivo in tumor tissues (Granot, Addadi et al. 
2007). 
2.2. 
Figure 2.1: Illustration of the difference between single-photon and two-photon excitation (arrow) -
taken from (Oheim, Michael et al. 2006). In single-photon excitation all the fluorophores in the laser 
path are excited, while in a two-photon excitation event, excitation is limited to the focal plane. 
Principle of Multiphoton Excitation Microscopy 
2.2.1. Two-photon Excitation Probability 
In two-photon microscopy, two-photon excitation is introduced by very high instantaneous power 
generated by a femtosecond pulsed laser. With a mode-locked Titanium.Sapphire laser generating 
ultra-short pulse with a pulse duration ( r ) of about 100 fs at a repetition rate of about 80 MHz, 
the probability of a fluorophore at the focal plane absorbing two photons simultaneously to reach 
the excited state becomes favorable (Denk, Strickler et al. 1990). For a given average laser power 
( P ) , the two-photon excitation probability (na) of a fluorophore at the focal plane is given by 
(Denk, Strickler et al. 1990), 
Equation 2.1 
n„ 
P S ( NA1 ^ 
f t \2kcA 
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where 8 is the two-photon absorption cross section of the fluorophore with X as the excitation 
wavelength, t is the pulse width, and f is the repetition frequency. NA is the numerical 
aperture of the lens, ti is the Planck's constant and c is the speed of light. Equation 2.1 is valid 
for two-photon excitation of the fluorophores at the tissue surface. For two-photon excitation 
deep inside the media, the scattering of light, which lowers the effective laser power at the focal 
plane and will accordingly lower the two-photon excitation probability of the fluorophores, needs 
to be considered. The maximum imaging depth (Zmax ) of two-photon excitation microscopy for a 
given average output power ( P ) is given by (Theer, Hasan et al. 2003), 
Equation 2.2 
where ls is the scattering mean-free-path, or the average distance between two successive 
scattering events. 
Equation 2.3 
tj2 is the fluorescent quantum efficiency for two-photon excitation, which is the same as 
that of the one-photon excitation (Xu and Webb 1996). </>{ZMAX) is the collection efficiency, 
which is related both to the acquisition system and wavelength of the generated fluorescence. A 
longer emission wavelength would have higher collection efficiency because the emission 
photons undergo less scattering when travelling back to the tissue surface. P(Zm a x) is the 
required average excitation power at the focal plane, which is related to the two-photon 
absorption cross section of the fluorophore (Theer, Hasan et al. 2003). 
2.2.2. Improvement of Imaging Depth 
By using NIR pulsed lasers, two-photon excitation microscopy generates images from deeper-
tissue with exceptional optical sectioning and is particularly well suited for in vivo imaging of 
live animals. However, its imaging depth is mostly limited to the tissue surface. Because of the 
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strong scattering of the excitation light, the maximum imaging depth ever shown in vivo has only 
been about 600-800 (xm in the neocortex of both mice and rats (Svoboda, Denk et al. 1997; 
Svoboda, Helmchen et al. 1999; Nimmerjahn, Kirchhoff et al. 2004). Optimization for deeper 
tissue imaging can use the following approaches to maximize two-photon excitation probability 
and to improve imaging depth. 
a. Excitation wavelength: Scattering mean-free-path depends on the excitation 
wavelength, and longer wavelengths undergo less scattering (Helmchen and Denk 2005). When 
the scattering is less, more incident photons reach the focal plane, resulting in better excitation 
probability and imaging depth. Measurements in brain gray matter showed a ls of 50-100 |xm at 
630 nm in extracted tissue (Yaroslavsky, Schulze et al. 2002) and about 200 |im at 800 nm in vivo 
(Oheim, Beaurepaire et al. 2001). In addition to the excitation lights, the emission lights undergo 
scattering in the same way when they travel back to the tissue surface. Fluorophores, which can 
be excited with longer wavelengths, usually have longer emission wavelengths; thus more 
emission photons are able to travel back to the tissue surface, resulting in better collection 
efficiency and larger imaging depth. Optical parametric oscillators (OPO) can be used to extend 
the spectral range of Titanium:Sapphire lasers to a longer wavelength (up to -1500 nm) to 
increase excitation probability and imaging depth. 
b. Pulse width: One problem associated with ultrashort pulses (-100 fs) is that they are 
dispersed while propagating through the optical system. Chromatic or group velocity dispersion 
(GVD) occurs because longer-wavelength ('red') components of the pulse travel faster in optical 
materials than shorter-wavelength ('blue') components, resulting in a broadened, or chirped pulse 
(Flusberg, Cocker et al. 2005). Since the peak power at the focal plane can be defined as the pulse 
energy divided by the pulse width (Wolleschensky, Dickinson et al. 2002), GVD will therefore 
reduce two-photon excitation efficiency. However, by giving the short-wavelength components a 
sufficient lead, a process called negative pre-chirp, it is possible to compensate for the GVD by 
letting the blue and red components arrive at the sample at the same time (Helmchen and Denk 
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2005) (Figure 2.2). Such compensation is useful in increasing excitation efficiency without 
increasing the average power since too much power from the IR light can produce heat in samples 
and damage vital functions (Helmchen and Denk 2005). 
A) 
Laser Optics Femto 
Control 
B) 
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Control Optics 
Figure 2.2: Two diagrams of prechirping by using a FemtoControl pulse compressor (APE, 
Inc.) -taken from (Marz 2007). A: Chirped pulse after optics can be compensated for by using a 
pulse compressor before reaching the specimen. B: Laser pulse can be pre-chirped by the 
Femto Control before the optics to pre-compensate for the GVD, which will be generated by 
the optics. 
c. Pulse repetition rate: The efficiency of nonlinear excitation, with same average power, 
can be increased by reducing the pulse repetition frequency ( / ) (Beaurepaire and Mertz 2002). 
One can achieve a lower repetition rate by increasing the cavity length of the oscillator or by 
cavity dumping (Theer, Hasan et al. 2003). So far, the lowest repetition rate achieved by 
increasing cavity rate is ~4MHz (Cho, Kartner et al. 2001), and it can go up to 950 KHz by cavity 
dumping (Ramaswamy, Ulman et al. 1993). Both methods suffer a significant loss of average 
power. This loss can be avoided by use of a regenerative amplifier, which amplifies a submultiple 
of pulses from an oscillator (Helmchen and Denk 2005). Peak power increased by as much as 108 
has been reported (Wang, Backus et al. 1999) by using a regenerative amplifier. It is feasible to 
use a regenerative amplifier to enhance penetration depth (Beaurepaire, Oheim et al. 2001) up to 
1000 |xm in vivo (Theer, Hasan et al. 2003). 
d. Two-photon absorption cross section ( S ) and quantum efficiency (r/2): Besides 
improvement in the excitation system, two-photon excitation probability can be enhanced by 
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using brighter fluorophores with a higher two-photon absorption cross section and quantum 
efficiency. 
2.2.2.1. Optical Parametric Oscillators (OPO) 
The spectral range of Titanium:Sapphire lasers can be extended using an OPO. Optical parametric 
generation is fundamentally different from light amplification by stimulated emission that occurs 
in a laser. In a laser, population inversion must occur such that more gain centers are in an excited 
state than in the ground state. Stimulated emission from these excited states leads to the gain 
exhibited by a laser (Slusher 1999). Unlike the situation in a laser, there is no excited state in the 
parametric converter. Electrons in a nonlinear medium are accelerated directly by the electric 
field of the pump laser beam, generating their own oscillating electric field. In a linear medium, 
this generated electric field propagates in the same direction, phase and frequency as the incident 
wave. However, in a nonlinear medium, the response field is not limited to the same frequency as 
the driving wave (Radunsky 1995). The nonlinear response of an OPO involves the interaction of 
three optical fields, ©i, co2, and ©3. Typically, ©3, called a pump frequency, is the frequency of 
the driving field which is incident on a nonlinear crystal. The response of the nonlinear crystal 
converts the pumping frequency into two new lower frequencies, C0i and CO2, such that energy is 
conserved (©3 = CO] + ©2). (Di and 0)2 are called signal and idler frequencies, respectively (Byer 
1975). The energy conservation can be matched by infinite combinations of idler and signal 
frequencies. In an optical parametric oscillator, only a single pair of signal and idler frequencies, 
which satisfies the phase matching condition (conservation of momentum) with the pumping 
frequency, causes the OPO cavity to resonate (Byer 1975). The frequencies that satisfy the phase 
matching condition are called the mode pairs. By adjusting the pump-laser wavelength, or the 
phase angle between the oscillator axis and the crystal axis, we can tune the wavelengths of the 
signal and idler outputs smoothly (Radunsky 1995). 
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Recently, with the advent of periodically poled nonlinear crystals, phase matching can be 
attained by changing the length of the OPO cavity rather than changing the phase angle between 
the oscillator axis and the crystal axis (Coherent 2008). The output wavelengths are a function of 
the length of the OPO cavity which can be changed electronically. When using a 
Titanium .-Sapphire laser at 835 nm wavelength as a pumping source, the output from this kind of 
OPO ranges from 1090 nm to 1500 nm, and the power ranges from 350 mW to 600 mW. 
2.2.2.2. Pre-chirping Technique: 
Ultra fast lasers emitting femtosecond pulses are required for multiphoton excitation of 
fluorescent dyes. However, laser pulses with pulse duration of less than 10 picoseconds (ps) are 
stretched by the GVD when passing through optical components, such as a lens (Marz 2007). It 
leads to a time delay between the different wavelength parts, and this time delay (positively 
chirped pulse) remains constant when the pulse leaves the medium (Flusberg, Cocker et al. 2005) 
(Figure 2.3). GVD reduces peak power at the focal plane by broadening the pulse width 
(Wolleschensky, Dickinson et al. 2002), resulting in reduced two-photon excitation efficiency. 
However, it is possible to compensate for the GVD by pre-chirping the pulse using configurations 
of prisms (Fork, Brito Cruz et al. 1987). These prisms first separate different wavelength 
components spatially. Then, through imposing different path lengths inside the prisms, 
wavelengths that travel slower in optical components are given a lead. Different spectral 
components will finally be recombined before entering the microscopy system. The spacing 
between these components determines the amount of negative pre-chirp (Treacy 1969). Figure 2.4 
illustrates a pulse compressor assembled by the use of two prism pairs. The chirp of the pulse, C, 
is expressed in terms of the product of time and bandwidth (Wolleschensky, Dickinson et al. 
2002) 
Equation 2.4 
TACO = 41n(2)Vl + C2, 
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where Aco and r are the spectral bandwidth and the pulse length of the pulse 
respectively. The GVD of a material is described by the dispersion parameter /?2 and the length 
of the material z. Then GVD can be calculated from material constants in terms of the second 
derivative of the refraction index with respect to the wavelength A (Wolleschensky, Dickinson et 
al. 2002), 
Equation 2.5 
_ ^ z d2n 
P 2 IncldX2^ 
where Co is the speed of the light and A o is the excitation wavelength. The dispersion 
parameter for the whole microscopy system can be calculated by summing all individual 
parameters of each optical element. Using Equation 2.4 and Equation 2.5, the pulse width at the 
output of the material, t , can be calculated using the following equation (Wolleschensky, 
Dickinson et al. 2002), 
Equation 2.6 
2 
where r 0 is the pulse width before the input of the material. Based on Equation 2.6, 
larger GVD is expected with smaller pulse width of the input laser (Wolleschensky, Dickinson et 
al. 2002). 
r = rn 1 + 
41n(2 ) P t z C 
+ 
41n(2)/?2z 
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Figure 2.3: Positive and negative GVD-taken from (Marz 2007). A) Positive GVD: A 100 fe pulse is broaden 
to 160 fs after transmitting through a 10 cm BK 7 glass B) Negative GVD: The blue wavelength parts travel 
faster than the red wavelength parts after the prism pair 
Figure 2.4: The principle of a prism pulse compressor -taken from (Marz 2007). The prism P1 splits up the 
polychromatic light of the laser pulse into the respective spectrum. Different wavelengths propagate 
parallel to each other. To reverse the spectral splitting of the beam after the compressor, P3 and P4 are 
set up symmetrically to the prisms P2 and P1. Negative dispersion is caused by the different optical path 
length in prism P2 and P3, according to the respective wavelength. Moving the prisms along the beam 
direction can change the thickness of the material for all wavelengths by the same degree and can 
change the amount of chirping. 
2.3. Contrast Agents for Two-Photon Excitation Microscopy 
2.3.1. Current Contrast Agents 
Fluorescent proteins are genetically encoded endogenous fluorescent reporters used in biomedical 
research. They can be genetically fused to the promoters and enhancers of the genes of interest, 
providing an efficient way to recapitulate the expression pattern of these genes without 
exogenous interference. Various colors of fluorescent proteins have been engineered to cover the 
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whole visible spectrum from blue to red, realizing multiple-labeling experiments with minimal 
crosstalk in their excitation and emission channels (Figure 2.5) (Attisano and Wrana 2002; Nagai, 
Ibata et al. 2002; Zapata-Hommer and Griesbeck 2003; Rizzo, Springer et al. 2004; Shaner, 
Campbell et al. 2004; Wang, Jackson et al. 2004; Nguyen and Daugherty 2005). While 
fluorescent proteins can express efficiently and without toxicity in transgenic animal systems, 
they usually suffer low photostablility and, more importantly, low two-photon absorption cross 
section and quantum efficiency. 
To increase contrast in the NIR fluorescence imaging, most in vivo studies employ 
exogenous contrast agents. Figure 2.6 illustrates the optical properties of some common chemical 
fluorophores. Compared to fluorescent proteins, organic dyes (such as heptamethine 
indocyanines) have a higher two-photon cross section. However, they also confront limitations. 
Sophisticated chemistry is required to tune the chemical structures of the fluorophores in order to 
control their excitation and emission wavelengths (Frangioni 2003). In addition, organic 
fluorophores are highly vulnerable to photobleaching (Frangioni 2003), limiting their application 
in long-term live animal imaging. 
Inorganic fluorescent semiconductor nanocrystals, on the other hand, possess much 
higher two-photon excitation cross sections (2,000-47,000 GM (Wang, Huff et al. 2005)) and are 
remarkably resistant to photobleaching (Frangioni 2003; Wu, Liu et al. 2003). However, their 
toxicity has been reported (Shiohara, Hoshino et al. 2004; Lovric, Bazzi et al. 2005; Hardman 
2006), limiting their use for in vivo imaging. Therefore, using non-toxic exogenous contrast 
agents with a good nonlinear two-photon cross section, fluorescence quantum efficiency and 
resistance to photobleaching is a more biologically desirable approach to extend depth penetration 
in two-photon excitation microscopy. 
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Class Protein 
Source laboratory 
(references) 
Excitation0 
(nm) 
Emission*1 
(nm) 
Brightness® Photostability' pKa Oligomerization 
I Far-red mPlum9 Tsien C5) 590 649 4.1 53 <4.5 Monomer 
Red mCherryS Tsien (4) 587 610 16 96 <4.5 Monomer 
tdTomato9 Tsien (4) 554 581 95 98 4.7 Tandem dimer 
mStrawberryS Tsien (4) 574 59$ 26 15 <4.5 Monomer 
J-Redh Evrogen 584 610 8.8" 13 5.0 Dimer 
DsRed-monomer* Clontech 556 586 3.5 16 4.5 Monomer 
Orange mOrangeS Tsien (4) 548 562 49 9.0 6.5 Monomer 
mKO MBL Intl. (10) 548 559 31' 122 5,0 Monomer 
Yellow-green mCitrine' Tsien (16.23) 516 529 59 49 5.7 Monomer 
Venus Miyawaki (1) 515 528 53* 15 6.0 Weak dimer-j 
YPets Daugherty (2) 517 530 80" 49 5.6 Weak dimepj 
EYFP Invitrogen (18) 514 527 51 60 6.9 Weak dimeF) 
Green Emerald9 Invitrogen (18) 487 509 39 0.69k 6.0 Weak dimepj 
EGFP Clontech' 488 507 34 174 6.0 Weak dimer-j 
Cyan CyPet Daugherty (2) 435 477 18' 59 5.0 Weak dimepi 
mCFPfn1" Tsien (23) 433 475 13 64 4.7 Monomer 
Cerulean9 Piston (3) 433 475 27' 36 4.7 Weak dimer-j 
UV-excitable green T-Sapphire9 Griesbeck (6) 399 511 26' 25 4.9 Weak dirtied 
Figure 2.5: Best fluorescent proteins of each color -taken from (Shaner, Steinbach et al. 2005). 
Extrinsic fluorophores X (nm) <*2 
Bis-MSB 691/700 6-0+1-8 6-3 + 1-8 
Bodipy 920 17 ±4-9 -
Calcium Green 740-990 - ~80 
Calcofluor 780/820 - -
Cascade Blue 750-800 2-1 ±0-6 
Coumarin 307 776, 700-800 19 + 5-5 ~20 
CY2 780/800 - -
CY3 780 - -
CY5 780/820 - -
DAPI (free) 700/720 0-16 + 0-05 ~3-5* 
Dansyl 700 1 -
Dansyl hydrazine 700 0-72 + 0-2 -
Oil 700 95 + 28 -
Filipin 720 - -
FITC 740-820 - - 2 5 - 3 8 * 
Fluorescein (pM~l l ) 780 - 38 + 9-7 
Fura-2 (free) 700 11 -
Fura-2 (high Ca) 700 12 -
Hoechst 780/820 - -
Indo-1 (free) 700 4-5 + 1-3 12 + 4 
Indo-1 (high Ca) 590/700 1-2 + 0-4 2-1+0-6 
Lucifer Yellow 840-860 0-95 + 0-3 ~ 2 
Nile Red 810 - -
Oregon Green Bapta 1 800 - -
Rhodamine B 840 - 210 + 55 
Rhodamine 123 780-860 - -
Syto 13 810 - -
Texas Red 780 - -
Triple probe (DAPI, FITC', and Rhodamine) 720/740 - -
TRITC (Rhodamine) 800-840 - -
Figure 2.6: Properties of some common fluorophores under two-photon-excitation -taken from (Diaspro, 
Chirico et al. 2005). 
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2.3.2. Potential Nanoparticles 
Gold nanoparticles with their special optical properties and inherent biocompatibility are 
emerging as promising luminescent contrast agents for deep tissue imaging. They are stable and 
non-toxic in vivo, do not photobleach and have a high absorption cross section. All of these 
desirable properties increase their potential for development as a new class of contrast agents for 
two-photon excitation microscopy. 
Gold nanorods are elongated nanoparticles whose optical properties are determined by 
the aspect ratio of the rods (defined as the ratio of length to diameter) (Murphy, Sau et al. 2005; 
Hu, Chen et al. 2006). These nanoparticles exhibit two localized surface plasmon resonances 
(LSPR) in their extinction spectra: the transverse and the longitudinal (Murphy, Sau et al. 2005). 
The transverse LSPR results from excitation across the diameter, whereas the longitudinal LSPR 
results from the excitation across the length (Murphy, Sau et al. 2005). Studies have shown their 
use as optical contrast agents for in vitro imaging of tissue sections or cell cultures (Sokolov, 
Follen et al. 2003; Yelin, Oron et al. 2003; Orendorff, Sau et al. 2006) and, more recently, for in 
vivo imaging with live animal models (Wang, Huff et al. 2005). It has been demonstrated that 
strong NIR excited two-photon-induced photoluminescence (TPIP) from a single gold nanorod, 
was 58 times brighter than that from a single Rhodamine 6G molecule (Wang, Huff et al. 2005). 
In addition, their NIR two-photon excitation cross sections (2,320 GM) has been deemed 
comparable to that of quantum dots (2,000-47,000 GM) (Wang, Huff et al. 2005). 
Gold nanoshells are composite nanoparticles that combine infrared optical activity with 
the non-cytotoxicity of gold colloid (Hu, Chen et al. 2006). Similar to gold colloids, gold 
nanoshells exhibit strong scattering and absorption effects because of the strong plasmon 
resonance of the metallic-dielectric concentric spherical configuration (Oldenburg, Averitt et al. 
1998; Averitt, Westcott et al. 1999). Peaks of scattering and absorption can be fine tuned by 
varying the geometry or layering of the materials from the visible wavelength into the NIR, a 
region of highest physiological transmissivity (Oldenburg, Jackson et al. 1999), thus providing a 
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means of making the signal distinguishable from autofluorescence or other fluorescent probes. 
Additionally, they can be made to either preferentially absorb or scatter light by varying the 
relative dimensions of the core and shell layers given a certain wavelength of the light for 
excitation. The absorbed energy is commonly released as heat and luminescence. It has been 
shown that the TPIP of gold nanorods and gold-silica nanoshells are approximately equal while 
fluorescent beads require 12 times higher laser power than nanoshells to emit the same 
fluorescent intensity (Park, Estrada et al. 2008). The same study also showed that nanoshells 
produce signals 140 times brighter than fluorescent beads with the same incident power. (Park, 
Estrada et al. 2008). 
Gold nanocages are similar to nanoshells in that their plasmon resonance can be tuned 
from the visible to the NIR region (Sun and Xia 2002; Sun, Wiley et al. 2004). They have 
stronger absorption in the NIR (Hu, Chen et al. 2006) compared to nanoshells, indicating possibly 
stronger luminescence. Gold nanocages have already been successfully used as contrast 
enhancement agents for OCT (Cang, Sun et al. 2005) and targeted photothermal agents for the 
destruction of cancer cells (Chen, Wang et al. 2007). With their desirable properties, Au 
nanocages should find their use in NIR luminescence imaging. Collectively, these desirable 
optical properties, in addition to their biocompatibility, make gold nanoparticles highly attractive 
as potential luminescent contrast agents for NIR excitation. 
2.4. Biomedical Applications of Two-photon Excitation Microscopy 
The capability of imaging several hundred microns deep into living animals has led to a rapid 
expansion of the use of two-photon excitation microscopy for high-resolution imaging in various 
fields of biomedical research. Two-photon microscopy has been used to excite different 
fluorophores with various emission spectra using the same excitation wavelength (Zipfel, 
Williams et al. 2003) as well as excitation of intrinsic fluorophores (Campagnola, Millard et al. 
2002; Wang, Wyckoff et al. 2002; Dombeck, Kasischke et al. 2003; Zipfel, Williams et al. 2003). 
In rat brain slices, the release of neurotransmitters was measured at the single-synapse level using 
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a two-photon microscope, enabling analysis at the cellular scale. (Oertner 2002). Two-photon 
microscopy was also used to quantify stem cell markers (Rice, Kaplan et al. 2007) in cell culture 
and to characterize the dynamics of thymocyte-stromal cell interactions in a thymus organ culture 
system (Bousso, Bhakta et al. 2002). For in vivo imaging, two-photon microscopy has been used 
to study fibroblast migration in the tumor tissue (Granot, Addadi et al. 2007) and to calculate 
blood flow rate (Kleinfeld, Mitra et al. 1998) (Figure 2.7). Most importantly, it has been used for 
long-term imaging on live animals. Figure 2.8 shows different types of brain access, which are 
widely used for long-term imaging of brain tissue over days to months. Animals are 
reanesthetized each time, and images can be acquired from the same brain window (Helmchen 
and Denk 2005). 
In order to image free-moving animals in their physiological condition without repeated 
anesthetizations, efforts have been made to use a very narrow objective lens made from gradient-
index (GRIN) materials (Figure 2.9) (Jung and Schnitzer 2003; Gobel, Kerr et al. 2004; Jung, 
Mehta et al. 2004; Levene, Dombeck et al. 2004). These probes enable minimally invasive 
imaging of individual cells deep within the tissue (Jung and Schnitzer 2003; Jung, Mehta et al. 
2004). The GRIN lenses are implanted into the animal's brain with the other end positioned at the 
focal plane of the objective lens. The scanning beam from a two-photon microscope is refocused 
by the GRIN lens on to the specimen, and the emission light is collected back using the same 
GRIN lens. 
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Figure 2.7: Characterization of flow rates using line scan through examining the basal motion of red 
blood cells (RBCs) in capillaries in the rate neocortex - taken from (Kleinfeld, Mitra et al. 1998). The 
laser was directed to scan along the central longitudinal axis of the vessels. Red blood cells appear 
as the dark spots in the fluorescent contrast agent-labeled capillary. Vessels with different flow rates 
were scanned at different scanning speeds (a, b: 2 msec/line, c: 1 msec/line). The widths of the dark 
bands (distance between arrows) appeared to be decreasing with increasing flow rate, which is 
caused by the decreasing profile (from a to c) of the RBCs relative to the central axis of the capillary. 
Ax is the spatial difference of the blood cells within the line scan interval At, which could be calculated 
by the pixel size and scanning speed, respectively. Ax/At is the instantaneous blood flow velocity. 
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Figure 2.8: In vivo imaging in the neocortex using two-photon microscopy taken from (Helmchen and Denk 
2005). (a) Different strategies for brain imaging. Cranial window can be opened for insertion of micropipettes 
for cell labeling and physiological recording (top). Thinned-skull can be imaged directly (middle). Implanted 
coverglass serves as a window for long-term imaging (bottom), (b) An example of 3-D reconstructed mouse 
neocortex structure imaged with two-photon excitation microscopy. 
Figure 2.9: Experimental setup for in vivo imaging using GRIN lens conjugated with two-
photon microscopy - taken from (Levene, Dombeck et al. 2004). 
42 
2.5. Conclusions 
Two-photon excitation microscopy is a powerful tool to visualize cellular structure within highly 
scattered tissue in vivo. It carries the advantages over other imaging technologies because it 
enables deeper tissue imaging with sub-micron resolution. These unique features have led to 
numerous biomedical applications in cell biology and neurosciences, as well as biomaterials. 
Even though several contrast agents are available for two-photon excitation, limitations such as 
low two-photon excitation cross section and low phtostability (Frangioni 2003), impede their 
application. These limitations also negatively restrict the imaging depth of the two-photon 
excitation technique. The development of nano-scale, ultra bright and biocompatible probes is 
therefore important to improving this imaging technique and significantly expanding its 
application fields. Most importantly, if these probes can be used as contrast agents for imaging 
with an OPO or a pre-chirp unit, which has been shown to improve the excitation probability, the 
synergy could be significant in further enhancing the imaging depth. Finally, the capability of 
imaging these nanoparticles in vivo may enable applications for combined diagnosis and 
photothermal therapy for disease on the single particle level in the future. 
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3. Nanoshells in vivo Imaging Using Two-photon Excitation Microscopy 
3.1. Introduction 
Gold nanoshells have been intensively investigated and applied to various biomedical fields 
owing to their flexible optical tunability (Prodan and Nordlander 2003) and biological 
compatibility. A major interest is their ability to absorb light in the optically transparent NIR 
window and generate heat to kill tumor cells (Hirsch, Stafford et al. 2003). In addition, because of 
their scattering and absorption properties, nanoshells are used in different imaging applications 
such as, scattering-based OCT (Gobin, Lee et al. 2007) and luminescence-based optical 
microscopy (Bickford, Sun et al. 2008; Park, Estrada et al. 2008). Compared to other scattering-
based imaging techniques, which highly rely on the inherent variation in refractive indexes of the 
tissue in order to provide contrast (Huang, Swanson et al. 1991), a luminescence-based 
microscopy system can better reveal the object of interest in an otherwise dark background. For 
example, confocal and two-photon microscopies provide exceptional optical sectioning capability 
and target-to-background contrast at the sub-micron resolution. They present a platform for small 
animal high-resolution imaging and molecular targeting. Nanoshells hold a substantial potential 
for this technique since they have been shown to have a much higher luminescence than similar 
sized contrast agents (Park, Estrada et al. 2008). As discussed in Chapter 2, brightness of the 
contrast agents is one of the factors determining the imaging depth; therefore nanoshells can 
potentially extend the imaging depth of two-photon microscopy. Thus far, most of the studies on 
two-photon luminescence imaging of nanoshells have been focused on passive (Park, Estrada et 
al. 2008) or antibody-induced (Bickford, Sun et al. 2008) accumulated nanoshells. However, 
accumulated nanoshells could have optical properties different from single nanoshell particles 
depending on the extent of accumulation (Lassiter, Aizpurua et al. 2008). Therefore their optical 
properties could differ between experiments, and such inconsistency makes direct interpretation 
of nanoshell emissions difficult and thus reduces its versatility as a contrast agent. 
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This chapter discusses the successful in vivo demonstration of NIR gold-silica nanoshells 
for small animal imaging using a sub-jim wavelength Titanium: Sapphire laser. The approach 
discussed in this chapter uses monodispersed nanoshells as contrast agents for vessel imaging. 
The following sections will be dedicated to identifying flowing single nanoshells in vivo, 
comparing the brightness of nanoshells with that of commercialized dyes and demonstrating the 
optical contrast attributable to nanoshells in blood vessel imaging. These results present 
considerable potential for the engineering of nanoshells with controlled optical properties for in 
vivo imaging and , as a result, improving the imaging depth of two-photon excitation microscopy. 
Additionally, this strategy promises a new approach for future high-resolution combined imaging 
and therapy for cancer. 
3.2. Hypothesis and Specific Aims 
The hypothesis of this portion of the research is that the luminescence of single gold-silica 
nanoshells can be used to provide optical contrast for NIR imaging of blood vessels. The specific 
aims are: 
a. To synthesize and characterize nanoshells with peak of plasmon resonance 
in the NIR region 
b. To verify the presence of nanoshells in the blood vessels 
c. To detect and characterize single nanoshells in vivo 
3.3. Methods and Materials: 
3.3.1. Nanoshell Synthesis and Characterization 
The fabrication protocol used for nanoshells includes molecular self-assembly and colloid 
chemistry in aqueous solution (Westcott, Jackson et al. 2002). Silica cores were made by the 
Stober method, which involves the reduction of tetraethylorthosilicate (TEOS, Aldrich) in 
ethanol. Next, the Stober nanoparticles were functionalized with aminopropyltriethoxysilane 
(APTES, Aldrich), resulting in silica cores with attached amine groups. When these 
functionalized groups were placed in a gold colloid solution, small gold colloids adsorbed to the 
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amine group. These small gold colloids (1-3 nm) were fabricated according to the method of Duff 
and Baiker (Duff, Baiker et al. 1993). Gold colloids provide the nucleation sites for further 
reduction of gold. As gold reduces onto the colloid, the colloids grow until the complex coalesces 
into a complete shell. The amount of gold added during this final reduction stage determines the 
shell thickness. Gold nanoshell sizes were determined by scanning electron microscopy (SEM), 
and their absorbance was measured with a spectrophotometer (Cary 5000, Varian). Before the 
experiments, nanoshell surfaces were modified with thiolated polyethylene glycol (PEG) to 
provide steric stabilization as well as to eliminate non-specific protein adsorption. 
3.3.2. Luminescent Spectrum of Nanoshells 
A drop of nanoshell solution at a concentration of 3.5 x 109 particles/ml was dried on a glass slide 
and was then imaged with a Zeiss Plan-Apochromat 20X, NA=0.75 objective lens using a two-
photon excitation microscope (Zeiss, 510 MET A) coupled to a Coherent Chameleon tunable 
titanium:sapphire laser (Coherent Laser Group, Santa Clara, California). The laser was tuned to 
750 nm and 800 nm for excitation. The emission signal was collected from 380 - 640 nm using a 
built-in spectrometer (META) with spectral resolution of 20 nm. The META detector can be used 
to collect images at different wavelengths simultaneously. The signals used in the measurement 
of the spectrum came from single pixels in the image at IX zoom at which the pixel size was 850 
nm. To further characterize the imaged particles as single particles or aggregates, a higher digital 
magnification using the same lens was employed to image the same particles using a smaller 
pixel size. Most of these signals were confined to a single pixel size of 250 nm at 3.5X 
magnification. Under these conditions, the pixel size was comparable to the size of a single 
nanoshell. Based on this observation, we argue that the emission spectrum came from single 
nanoshells, not nanoshell clusters. 
3.3.3. In vivo Model 
Mice on CD1 background were used for tail vein injection of PEGylated nanoshells. After 
injection, quadriceps muscles were exposed by surgery. In vivo imaging was conducted at the 
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veins on the surface of the quadriceps muscle. The same muscles were sectioned for ex vivo 
imaging after the in vivo imaging. This model was chosen because the veins on the surface of the 
quadriceps muscle can be easily exposed through local surgery and are within the imaging depth 
of the two-photon excitation microscopy. 
3.3.4. Immunostaining of the Tissue Sections after Nanoshells Injection 
PEGylated nanoshells were suspended in trehalose solution (2.33x1010 particles/ml) for tail vein 
injection. 150 fj.1 of nanoshells solution was injected along with 30 p.1 of fixable Dextran Oregon 
Green 488 (25 mg/ml, Invitrogen). Quadriceps muscles from the mice were sectioned after 
injection and then stained using antibodies against CD 31, which is an endothelial cell marker to 
label the vasculature. The cell nuclei were labeled with Hoechst while the vessel walls were 
labeled with Dextran after fixation. Using a 633 nm laser as the excitation source for nanoshells, 
the scattered light from the nanoshells in the wavelength region from 625 to 636 nm was 
acquired. 
3.3.5. In vivo Imaging of Nanoshells Using Two-Photon Excitation Microscopy 
150 |xl of the nanoshells solution described in section 3.3.4 was injected along with 50 |xl of 
fixable Dextran Oregon Green 514 (25 mg/ml, 70,000 MW, 2.15 x 1020 molecular/ml, Invitrogen) 
into the tail vein of CD1 mice. Mice injected with only 50 of fixable Dextran Oregon Green 
514 (25 mg/ml, 70,000 MW, 2.15 x 1020 molecular/ml, Invitrogen) were used as the control. 
Through local surgery, veins in the quadriceps muscles of the anesthetized mice were exposed 
and then imaged with a custom-built Zeiss Axioskop 2FS upright two-photon excitation 
microscope, mounted with a modified LSM DuoScan system, using a Zeiss Plan-Apochromat 
20X, NA=1.0 objective. A Titanium:Sapphire laser (Coherent Laser Group, Santa Clara, 
California) was tuned to 750 nm to excite the nanoshells and fluorescent Dextran. PEGylation 
was tested by monitoring the optical density (O.D.) of the PEGylated nanoshells in PBS, which 
was used to mimic the blood plasma. An O.D. curve without fast decrease indicates good 
PEGylation to prevent nanoshells from aggregation. 
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3.3.6. Ex vivo Imaging of Nanoshells Using Two-Photon Excitation Microscopy 
After in vivo imaging, quadriceps muscles of the mice were sectioned for two-photon imaging ex 
vivo. Mice receiving the same amount of nanoshells injection alone were used as a control. Tissue 
sections were fixed with 4% PFA and were stained with Hoechst. Samples were imaged with a 
custom-built Zeiss two-photon excitation microscope using a Zeiss C-Apochromat 32X, 
NA=0.85W objective lens. Nanoshells, Dextran, and Hoechst were excited using 750 nm, 850 nm 
and 720 nm lasers respectively. 
3.3.7. Ex vivo Imaging of Nanoshells Using Scanning Electron Microscopy (SEM) 
After the in vivo imaging, quadriceps muscles of the mice were embedded in paraffin and 
sectioned for SEM imaging ex vivo. Tissue sections were first rehydrated in water and then 
dehydrated with a graded series of increasingly concentrated ethanol for 5 minutes each. The 
samples were then transferred to graded series of increasingly concentrated hexamethyldisilazane 
(HMDS) for 5 minutes each and air dried overnight. In the next step, the samples were first 
coated with flash carbon under vacuum using a Balzer MED 010 evaporator (Technotrade 
International, Manchester, NH) and transferred to a desiccator for the dehydration process. 
Finally, the samples were imaged using a JSM-5910 scanning electron microscope (JEOL, USA, 
Inc., Peabody, MA) at an accelerating voltage of 15 kV. 
3.4. Results and Discussion: 
3.4.1. Nanoshell Fabrication and Characterization 
The nanoshells used in this experiment have an average core size of 132 nm in diameter and an 
average shell thickness of 23 nm. The overall diameter of these nanoshells is 178 ± 18 nm. The 
SEM images of the nanoshells are shown in Figure 3.1. The extinction spectrum of the nanoshells 
used in this study was simulated using a Windows-based program G-shell (Courtesy of Dr. 
Naomi Halas). Figure 3.2 shows that the measured extinction spectrum matches the simulated 
results, giving an extinction peak at 800 nm. 
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Figure 3.1: SEM image of the nanoshells. Nanoshells are 178 nm in diameter with a core size of 132 nm 
and shell thickness of 23 nm (Courtesy of Dr. Vengadesan Nammalvar). 
Experimental and Simulated Extinction Efficiency 
Figure 3.2: Extinction spectra of nanoshells used in this study (Courtesy of Dr. Vengadesan Nammalvar). 
Measured extinction spectrum and simulated results using G-shell are shown with blue and pink curves, 
respectively. 
3.4.2. Luminescence Spectrum of Nanoshells 
Figure 3.3 shows the spectrum measured from 380 to 640 nm, which shows an increasing trend as 
the emission wavelength increased even at 640 nm.The data points measured at 660 nm were not 
used since 660 nm was on the edge of the KP 660 emission filter. The global maximum in this 
range occurred at 640 nm, which is in the red region of the visible spectrum. Linear fits were used 
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to show the increasing trend, with R2 = 0.9125 for the 750 nm excitation and R2= 0.8585 for the 
800 nm excitation. Luminescence signals from the nanoshells show a similar spectral pattern 
using either 750 nm or 800 nm excitation. 
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Figure 3.3: Luminescent spectral of nanoshells used in this study. Data dots from 750 nm and 800 nm 
excitation were shown in blue and red separately. Linear fits were used to show the increasing trends of the 
data with R2 = 0.9125 for the 750 nm emission data and R2 = 0.8585 for the 800 nm emission data. 
3.4.3. Immunohistochemistry Staining 
Figure 3.4 illustrates a three-dimensional reconstruction of a z-stack taken using a Zeiss 510 
META microscope (Carol Zeiss Inc.). The vessels were labeled with both Dextran and CD31. 
Nanoparticles were observed inside the Dextran and CD31 -labeled vasculature. No nanoshells 
were observed outside the vasculature, indicating that all particles were confined to the vessels 
without leakage. 
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Figure 3.4: A three-dimensional reconstruction of a z-stack showing nanoshells inside the vasculature after 
tail vein injection. (A) cell nuclei labeled with Hoechst (B) vessels labeled with fixable Dextran (C) vessels 
labeled with antibodies against CD 31 (D) nanoshells acquired using their scattering property (E) merged 
image. Image was taken using a Zeiss 510 META microscope with a 40x NA = 1.2 W lens. 
3.4.4. In vivo Imaging of Nanoshells Using Two-Photon Excitation Microscopy 
Flowing particles were observed within Dextran-filled vessels (Figure 3.5 (A-C) ). The particles 
were absent in the control case, which received Dextran injection alone and imaged with same 
configurations (Figure 3.5 (E-G)) Luminescence emission from nanoshells was collected from 
520 nm to 640 nm with band-pass filters of about 50 nm in width. The emission intensity 
increased with the emission wavelength. The maximum emission intensity occurred when using a 
band-pass filter from 575 nm to 640 nm (BP 575-640), which was well within the pre-determined 
emission pattern of nanoshells. The PEGylation test showed less than a 5% drop of O.D. over 30 
minutes, which indicated that the tested PEGylated nanoshells did not aggregate in the PBS 
solution. Based on the brightness of the nanoparticles, they could be easily isolated from the 
Dextran signal. Figure 3.5 (D) and (H) are the isolated images from (C) and (G), respectively. 
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Pixel intensity from each channel (520-560 nm, 575-640 nm) ranged from 0-255. An intensity 
threshold of 250 was used for both channels to isolate nanoshells from the original vessel 
images. This threshold was used for both the nanoshells containing vessel images and the control 
images. Figure 3.5 (D) shows isolated nanoshell signals in the vasculature, and Figure 3.5 (H) as 
the control, shows little background using this method. 
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Figure 3.5: In vivo imaging of flowing nanoshells in the veins of the quadriceps muscle using two-photon 
excitation microscopy. (A) (B) show the emission signals in the wavelength ranging from 575-640nm and 
520 nm-560 nm respectively. (C) is the merger of (A) and (B), and (I) is an amplified image from the region 
of interest in (C). In these images, flowing particles (white arrows) were observed providing brighter signals 
than the Dextran. The main emission signal of Dextran 514 is in the 520 - 560 nm wavelength region, while 
its emission spans the range from 575 nm-640 nm. (E) (F) are from the control mice which received Dextran 
514 injection only using the same imaging settings. (G) is the merger of (E) and (F) and (J) is an amplified 
image from the region of interest in (G). Brighter nanoshells were isolated from the Dextran by thresholding. 
(D) and (H) are the isolated images from (C) and (G) respectively. The same threshold value was used in 
both cases. 
3.4.5. Ex vivo imaging of nanoshells 
In order to further optically separate the signals from the nanoshells from that of Dextran, muscle 
tissue was sectioned after in vivo imaging. Mice receiving nanoshells injection alone were used as 
a control. Although Dextran can be excited using a 750 nm wavelength laser in vivo, it can only 
be excited using an 800 - 850nm wavelength laser in fixed tissue sections. This observation may 
be due to that the majority of Dextran in the vessel lumen was lost during the fixation process, 
and only Dextran attached to the vessel walls was preserved, resulting in a much lower 
concentration and, hence, dimmer signal. The dimmer signal was no longer observable when 
imaged with a 750 nm laser off the excitation peak of Dextran. However, using an 800-850 nm 
laser at its excitation peak (Diaspro, Chirico et al. 2005), brighter Dextran signal was imaged. 
Figure 3.6 (C) shows scattered nanoshells (white arrows) inside the vessel in the tissue section, 
exhibiting the same patterns as those in Figure 3.5. Using 800 nm excitation and a 500 -550 nm 
filter, vessel lumen was labeled with fixed Dextran and nanoshells were observed inside of it 
(white arrows), showing a pattern identical of those in Figure 3.5 (B). In the control case, Figure 
3.6 (F) also shows the presence of nanoshells without Dextran injection. This result indicates that 
the bright flowing particles observed in vivo are nanoshells rather than aggregated Dextran or 
other background fluorescence from the tissue. 
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Figure 3.6: Ex vivo imaging of nanoshells in the tissue section. (A)-(C) are from the mouse received both 
Dextran and nanoshells injection. (D)-(F) are from the mouse received only nanoshells injection as a control. 
(A)(D) cell nuclei labeled with Hoechst (B) vessel lumen labeled with fixable Dextran. Bright nanoshells 
signals were observed as well (white arrows) (E) tissue autofluorescence (C) (F) nanoshell signal in the 
vessel (white arrows). Cell nuclei are visible because Hoechst emission spans into the 575-640 wavelength 
range when excited with a 750 nm laser. 
3.4.6. Single Particle Analysis 
In Figure 3.5 (A-C), bright particles were imaged flowing inside the vessels. In order to further 
identify these particles as single nanoshells or nanoshell aggregates, the particle concentration in 
circulation was analyzed. On average, the total blood volume in a mouse is 6-8% of its body 
weight, or 6-8 ml of blood per 100 g of body weight (Hoff and LVT 2000). Therefore, for a 20 g 
lab mouse, the total blood volume is 1.4 ± 0.2 ml. Given 2.33xl010 particles/ml as the injection 
concentration for nanoshells (150 (il nanoshell + 50 jil Dextran), the calculated blood 
concentration for single nanoshells will be 2.22 ± 0.28 x 109 particles/ml, assuming a uniform 
distribution of the particles inside the vasculature and no particles having been cleared from the 
blood after injection. In two-photon excitation microscopy, the excitation volume is on a sub-
femtolitre (fl) level (0.1-0.5 fl) (Diaspro, Chirico et al. 2005), which corresponds to about 1 |nm 
imaging depth. The particle density calculated from the 2D images was 2.08 ± 0.13 x 10 "3/ nm3. 
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In order to compare the calculated result with the experimental observation, 10 nanoshell pictures 
(similar to Figure 3.5 (C)) and five control pictures (similar to Figure 3.5 (G)) were used to 
calculate the particle density in the vessels. They were isolated in a manner similar to those in 
Figure 3.5 (D) and (H). The number of particles was calculated after isolation, and the areas of 
the vessels were measured with Zeiss LSM Image Browser software using Dextran defined vessel 
boundaries. The average background level due to Dextran from the control case was 8.1 x 10 "5 
particles/(im3, which was used as a baseline for the nanoshell density calculation. Our 
measurement determined that the average density of nanoshells was 1.53 x 10 ~3 particles/jam3, 
which equals 69% of the calculated value (Figure 3.7). Considering that the PEGylation test, 
which showed less than 5% drop of O.D. over 30 minutes in PBS, the measurement suggests that 
nanoshell aggregation was not a prevalent problem in vivo and that the flowing particles observed 
in vivo could be considered as single nanoshells. To test this hypothesis, tissue sections were 
imaged with SEM to further characterize the particles. Figure 3.8 illustrates the nanoshells 
imaged with SEM in the blood vessels. To test the single particle hypothesis, particles in the SEM 
images were isolated, and their sizes were measured. In Figure 3.9, 73% of the nanoshells have a 
size ranging from 160 nm to 200 nm, which is within the size variation of the nanoshells. 
Therefore, we conclude that the particles imaged in vivo were mainly single particles. There are 
two possible reasons that explain why only 69% of the calculated particle density could be 
concluded from the experiment. First, although in vivo imaging was conducted within a short time 
span (less than 30 minutes) after injection, it is possible that some particles were cleared out of 
the blood system. Second, it is possible that not all the particles were visible when imaged with 
the microscope; this is especially true for those nanoshells that were hundreds of micrometers 
beneath the tissue surface. 
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Figure 3.7: Nanoshell density analysis. Ten pictures from in vivo imaging were used to calculate the particle 
density in the vessels as the empirical result. An average of 1.53 x 10 3 particles/pm3 and 2.22 x 10 " 
particles/(jm3 were calculated for empirical and theoretical calculations, respectively. 
Figure 3.8: SEM images of tissue sections from in vivo imaging. 
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Figure 3.9: Size distribution of nanoshells. 73% of the nanoshells have a diameter ranging from 160 nm to 
200 nm, which is within the variation of the size of a single particle. 
3.4.7. Brightness Comparison 
In Figure 3.5 (A-C), nanoparticles appear to be much brighter than the Dextran fluorophore. 
Since most of these particles have been shown to be single particles, it is important to 
quantitatively compare their brightness with Dextran. Ten pictures that were similar to Figure 3.5 
(C) that combined the 520-560 nm and 675-640 nm band pass channels were used to evaluate the 
contrast enhancement of the nanoshells. Pixel intensities (0-255 for each band pass channels) 
from 20 nanoshells randomly chosen from these pictures were recorded. For each nanoshell, the 
average intensity of neighboring pixels was recorded as the brightness of Dextran. Then pixel 
intensities from the Dextran were used as the baseline for the calculation of pixel intensities from 
the corresponding nanoshells to determine the brightness for nanoshells. From the pixel intensity 
calculation, the brightness of the imaged nanoshells was determined. Figure 3.10 shows that the 
emission intensity of nanoshells is significantly different (P0 .001) from that of Dextran, and 
nanoshells provide a 3.17 times brighter signal. 
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Figure 3.10: Brightness comparison analysis. Emission intensity from nanoshells was recorded and 
compared to that from Dextran. Nanoshells have a mean emission intensity of 387.69 while Dextran has a 
mean intensity of 122.31. The difference in intensity between nanoshells and Dextran is significant 
(P<0.001). 
3.4.8. Contrast for the Vessels 
Given the low density of nanoshells in the vessels, a higher concentration of particles was tested 
(lOx, 2.33xlOn particles/ml) to better fill the vessels and to provide contrast. However, no in vivo 
imaging was recorded because of the fast photo damage of the vessel structure. This could be 
attributed to the photothermal effects from the nanoshells illuminated with the laser. Another way 
to provide better contrast is reconstruction from time series, which has been previously utilized to 
reconstruct bifurcation structure (Bagarinao, Pakdaman et al. 1999; Bagarinao, Pakdaman et al. 
2000). Although nanoshells were imaged at a low density inside the vessels, reconstruction from 
a time series acquired at the same place yields higher density of particles in the composite image, 
which will provide better contrast for the vessel structure (Figure 3.11). Figure 3.12 shows the 
reconstructed image. Ten pictures from a time series was used. The time series was from the in 
vivo imaging experiment shown in section 3.4.4. The nanoshells in each image were isolated 
using the same methodology as that of Figure 3.5 (D). The isolated images were combined and 
reconstructed into the final image as that shown in Figure 3.12 (B). Using this method, a higher 
density of nanoshells is accessible to provide contrast for in vivo vessel imaging. 
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Figure 3.11: Schematic of the reconstruction algorithm from time series. Flowing nanoshells are imaged 
inside the vessels. Ti, T2 and T3 represent images acquired in the same blood vessel at different time points. 
Nanoshells within the vessels are isolated and combined to provide enhanced contrast. 
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Figure 3.12: Optical contrast for vessel reconstructed using a time series from flowing nanoshells. (A) 
illustrates one picture in the time series used for reconstruction. (B) is the reconstructed image using ten 
pictures from the time series. 
3.4.9. Discussion 
Gold-silica nanoshells were engineered with the peak of extinction in the NIR region. Using a 
two-photon excitation microscope, the luminescent spectrum of the nanoshells was determined to 
have a broad range of emission with increasing trend toward longer wavelength. It is beneficial 
for NIR imaging since longer-wavelength emission light undergoes less scattering and enables 
better penetration depth. In the in vivo experiment, bright flowing particles were observed 
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together with fluorescent Dextran (Figure 3.5) while the control samples with only Dextran 
injection do not exhibit any visible contrast from the flowing particles. These bright particles are 
then confirmed to be nanoshells in the ex vivo experiment. To further characterize the flowing 
particles, concentration analysis was performed. The density of the flowing particles observed in 
the in vivo experiment accounts for 69% of the maximum possible particle density, assuming all 
particles were uniformly distributed in the vasculature after injection and no particles were 
cleared out of the blood system. Further SEM imaging (Figure 3.8) showed that around 73% of 
the particles in the tissue section remained as single particles. Therefore, it can be concluded that 
the flowing particles were mainly single particles. This result shows the potential of using 
nanoshells for single-particle-based in vivo imaging. The single particle approach is attractive 
since the nanoshells used for in vivo imaging can be easily characterized ex vivo. Compared to 
accumulated particles, whose optical properties are complex and difficult to predict owing to 
irregularities of particle accumulation, single particles behave in a controlled way between 
experiments, which is elucidated by Mie theory and can be analyzed consistently. Additionally, 
single particle approach possesses much broader imaging applications, such as vessel imaging 
and flow measurement, as well as luminescent tracking for small molecules transportation. 
While nanoshells produced a 3.17 times brighter emission than Dextran, the low density 
of nanoshells observed inside the blood vessels could potentially have a negative impact on their 
utility for vessel imaging as single particles. To solve this problem, two strategies were used. 
First, more concentrated particles were tested (lOx, 2.33xlOn particles/ml) to better fill the 
vessels. However, fast photo damage of the vessel structure prevented in vivo imaging. This could 
have resulted from the photothermal effects of highly concentrated nanoshells when exposed to 
the laser. As an alternative strategy, time series reconstruction was used. Time series was 
acquired at the same locations using a low concentration of nanoshells. The nanoshells from each 
image were isolated and combined to provide contrast for the vessel (Figure 3.11). 3-D vessel 
reconstruction could therefore be feasible by taking time series images from z-stacks. Using this 
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method, it is even possible to monitor structural changes of the vasculature in a long-term 
imaging process (Bagarinao, Pakdaman et al. 1999; Bagarinao, Pakdaman et al. 2000). 
Based on Figures 3.5 and 3.11, Dextran still seems to provide better vessel contrast 
because of its quantity and ease to be distributed in the blood vessels. By acquiring the time series 
reconstruction images to alleviate the issues caused by the low nanoshell density, nanoshells still 
holds great potential for deeper tissue imaging in which regions Dextran is no longer visible. For 
further vessel imaging experimentation, it would be possible to use antibody- or polymer-coated 
nanoshells targeting vascular endothelial cells to provide better contrast for the vessel structure. 
This imaging platform may have reduced imaging depth compared to the scattering-based 
OCT system; however it provides better resolution and has the ability to image and trace single 
nanoshells. This could be further exploited for a single-particle-based tracking system for drug 
delivery and for monitoring the accumulation of nanoshells in cancer tissue for photothermal 
therapy. 
3.5. Conclusions: 
The use of gold nanoshells as luminescent contrast agents for a high-resolution imaging platform 
has been demonstrated in this chapter. Using a two-photon excitation microscope, individual 
nanoshells were identified to provide contrast for blood vessels in vivo and showed a 3.17 times 
brighter signal compared to that of Dextran (Oregon Green 514). These findings suggest that 
gold-silica nanoshells with tunable optical properties can play a vital role in molecular imaging 
and be further developed into a new class of contrast agents for NIR luminescent imaging, and 
combined diagnosis and therapy. 
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4. Nanoshells ex vivo Vessel Imaging using an Custom-Built OPO and a 
Tg(Flk1-myr:.-Cherry) Transgenic Mouse Line 
4.1. Introduction 
Two-photon excitation microscopy extends the imaging depth of confocal microscopy while 
maintaining excellent optical sectioning capability. Nevertheless, the maximum imaging depth 
recorded in vivo is about 600-800 jxm in the brain tissue (Svoboda, Helmchen et al. 1999). In 
order to extend its imaging depth, the red region of the visible spectrum has attracted increasing 
attention because longer wavelength photons are less scattered by tissue, allowing better 
penetration. The quest for fluorescent makers in the red to NIR region led to the creation of 
fluorescent proteins like DsRed or mCherry (Shaner, Campbell et al. 2004), Katushka (Shcherbo, 
Merzlyak et al. 2007), as well as chemical dyes, such as Alexa Fluor 647, Indocyanine Green 
(ICG), and similar organic dyes. However, these fluorescent proteins and dye-based contrast 
agents are limited in number, and many of them have low quantum yield and limited 
luminescence (CCMI; Shaner, Campbell et al. 2004; Bardhan, Grady et al. 2008). Thus, although 
the spectral range can be effectively extended into longer wavelengths, more effective contrast 
agents are still needed to improve the efficacy of two-photon imaging. 
Titanium: Sapphire lasers are widely used for two-photon microscopy (Denk and Svoboda 
1997; Dickinson, Simbuerger et al. 2003) with a broad tunable spectrum from 680 - 1080 nm, but 
their spectral ranges can still be optimized for blue, green and near red fluorochromes. To excite 
the red fluorophores at their excitation peak, the spectral range of a Titanium: Sapphire laser can 
be extended to 1500 nm using an Optical Parametric Oscillator (OPO) (Vadakkan, Culver et al. 
2009). It has been shown that mCherry can be excited at an excitation peak of 1160 nm using an 
OPO pumped by a Titanium:Sapphire laser (Vadakkan, Culver et al. 2009). In addition, the OPO-
based two-photon imaging has recently been shown to improve imaging depth as well as reduce 
phototoxicity and photobleaching compared to the Titanium: Sapphire lasers-based microscopy 
system (Andresen, Alexander et al. 2009). Therefore, the benefits of extended imaging depth and 
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reduced phototoxicity and photobleaching effects make the OPO-based two-photon microscopy 
an attractive approach to high-resolution deeper tissue imaging. 
In Chapter 3, it was shown that gold-silica nanoshells can be tuned as luminescent 
contrast agents for a sub-(im wavelength Titanium:Sapphire laser with the maximum emission in 
the red region. Individual nanoshells are capable of providing a brighter signal than a widely used 
contrast agent. Therefore, combining the advantages of nanoshells and OPO laser systems, as 
discussed previously, presents a scenario in which the excitation range of two-photon imaging 
may be extended to the micrometer-level and the corresponding imaging depths may be improved 
for functional biological imaging of live organisms. 
In this chapter, gold-silica nanoshells that are tuned for an above l(im wavelength laser 
have been successfully imaged in blood vessels via intravenous injection into a transgenic mouse 
model. In this model, the blood vessels are labeled with mCherry fluorescent proteins, which can 
also be excited with the OPO laser. This experiment demonstrates that nanoshells can be excited 
at excitation wavelengths beyond the l|im upper limit of Titanium: Sapphire lasers. This 
observation demonstrates that the versatility of nanoshells, as a luminescent contrast agent, can be 
further improved when combined with OPO-based laser systems. More specifically, the two-
photon imaging regime has been extended into the micrometer-level NIR region, and deeper 
imaging depths as wll as improved signal-to-background contrast can be potentially achieved. 
4.2. Hypothesis and Specific Aims 
The hypothesis of this portion of the research is that gold-silica nanoshells can be tuned for NIR 
excitation using a micrometer-level laser and can therefore provide optical contrast for vessel 
imaging utilizing their luminescence. The specific aims are: 
a. To produce nanoshells with the peak of plasmon resonance in the NIR close 
to l|im wavelength 
b. To image nanoshells ex vivo in the blood vessels using a Tg(Flkl-
mry::mCherry) mouse line 
64 
4.3. Methods and Materials 
4.3.1. Nanoshell Synthesis and Characterization 
Gold-silica nanoshells were fabricated and characterized using the same methodology as 
described in Chapter 3. The extinction peak was tuned to near 900 nm, which is near the working 
range of the OPO. 
4.3.2. Imaging System Setup and Characterization 
The OPO system is based on the published work of Vadakkan, T. J., J. C. Culver, et al. A 
schematic of the OPO setup used in the experiments is shown in Figure 4.1. The OPO is pumped 
by a Titanium: Sapphire laser at 835 nm wavelength (Chameleon, Coherent Laser Group, Santa 
Clara, California), which was also used as the source for the two-photon excitation microscope 
discussed in Chapter 3. In order to adjust the laser power from the OPO output, a polarized half 
wave plate (HWP) was used. An acousto-optic modulator (AOM) was modified as a shutter to 
block the beam when the laser scanning microscope (LSM) is not scanning. The beam is aligned 
to fill the back aperture of the objective lens and maximize the illumination power on the 
specimen. 
Before imaging the nanoshells, the output laser from the OPO system was calibrated to 
ensure stable output and repeatability of the experiment. The output power of the OPO was 
measured by randomly using a power meter (S212A, Thermopile Sensor, Thorlabs) during a 
period of 15 days, and the power readings were then averaged. Similarly, the average power at 
the specimen was also measured with the Zeiss IR-improved 32x NA=0.85 W prototype objective 
lens, the same lens used to measure the power at the specimen. 
To further characterize the laser output from the OPO, the pulse width of the beam 
immediately after the telescope was measured using a Carpe autocorrelator (APE GmbH, Berlin). 
The output wavelength of the laser beam was electronically tuned on the OPO while the power at 
the specimen was maintained by adjusting the transmission through the HWP. By using the 
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PulseCheck software (APE GmbH, Berlin), the pulse width was measured from a hyperbolic-
secant-squared (sech2) fit to the intensity autocorrelation function. 
4.3.3. Animal Model 
A Tg(Flkl-myr::mCherry) endothelial reporter mouse line was used as the mouse model for ex 
vivo vessel imaging. This particular mouse line produces mCherry fluorescent protein in the 
endothelium and endocardium (Larina, Shen et al. 2009). mCherry is a monomeric red 
fluorescent protein derived from Discosoma Sp. Red fluorescent protein (Shaner, Campbell et al. 
2004). The excitation and emission wavelengths of mCherry are at 575 nm and 610 nm, 
respectively (Shaner, Steinbach et al. 2005). For two-photon excitation, mCherry has been shown 
to have an excitation peak at 1160 nm (Figure 4.3), using a custom-built OPO (Vadakkan, Culver 
et al. 2009). 
Since mCherry is strongly expressed in the forming vessels, both embryos and neonates 
exhibit strong mCherry expression around the vessels (Figure 4.2), and adult mice exhibit low 
expression of mCherry around the capillaries (Larina, Shen et al. 2009). The mCherry reporter is 
fused to a myristoylation motif (myr), and this fusion results in membrane localization of the 
fluorescent marker. The transgenic line is homozygosed and maintained on an FVB background. 
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Figure 4.1: A schematic of the OPO setup in this research - taken from (Vadakkan, Culver et al. 2009). The 
output from a Titanium:Sapphire laser (Chameleon, Coherent Laser Group) was reflected using a silver 
mirror to an OPO (Mira OPO, Coherent Laser Group). The output of the OPO was reflected using a 
Protected Gold (PG1) mirror (Thorlabs) to enter a half wave plate (HWP). The OPO has an emission 
wavelength range beyond the working range of an acousto-optic modulator (AOM) (up to 1064 nm), which is 
commonly used to adjust the beam power electronically; therefore, an HWP is used to adjust the power 
manually. The beam after the HWP was reflected by PG2 to a modified AOM, which serves as a shutter to 
block the beam when the laser scanning microscope (LSM) is not scanning. T refers to telescope, which 
was used to reduce the beam waist before it entered the scan head of LSM. By adjusting mirrors PG3, PG4, 
and PG, the beam was aligned until it filled the back aperture of the objective lens with maximum power at 
the specimen. The alignment was conducted with the help of a 633 nm laser line as the reference. 
Figure 4.2: A 3-D reconstruction from a z-stack of the mCherry-labeled vasculature in the skin tissue 
from a Tg(Flk1-myr::mCherry) neonate. An OPO laser was tuned to 1140 nm wavelength for 
excitation, and the imaging depth was 150 pm. 
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Figure 4.3: Excitation fingerprinting of mCherry using an OPO pumped by a TitaniunrvSapphire laser - taken 
from (Vadakkan, Culver et al. 2009). 
4.3.4. Ex vivo Imaging of Nanoshells Using the Tg(Flk1-myr::mCherry) Transgenic 
Mouse Line 
30 jal of PEGylated nanoshells solution (5xl09 particles/ml) was injected into the tail vein of a 
one-week-old mCherry mouse. Veins in the quadriceps muscles of the mice were exposed and 
then imaged with a custom-built Zeiss Axioskop 2FS upright two-photon microscope, mounted 
with a modified LSM DuoScan system. An IR-improved 32x NA= 0.85 W prototype lens (Carl 
Zeiss, Inc.) was used as the objective lens. An OPO (Mira OPO, Coherent Laser Group, Santa 
Clara, California) pumped by a Titanium: Sapphire laser (Coherent Laser Group, Santa Clara, 
California) at 835 nm was tuned to 1140 nm to excite the nanoshells and mCherry, and the laser 
power at the specimen was kept at 40 mW. 
4.4. Results and Discussion: 
4.4.1. Nanoshell Fabrication and Characterization 
The nanoshells used in this experiment have an average core size of 122 nm in diameter and an 
average shell thickness of 8 nm. The overall diameter of these nanoshells is 138 ± 14 nm. Figure 
4.4 shows the measured extinction spectrum together with the simulated results using G-shell, 
both showing the extinction peak at 910 nm. 
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Figure 4.4: Extinction spectra of nanoshells used in the OPO study (Courtesy of Dr. Vengadesan 
Nammalvar). Measured extinction spectrum and simulated results using G-shell are shown with blue 
and pink curves separately. 
4.4.2. Characterization of the Imaging System 
The laser output from the OPO can be tuned from 1120 nm to 1500 nm. Figure 4.5 shows 
the power at the output of the OPO before the HWP. Figure 4.6 illustrates the attenuated power at 
the specimen. Given that the common working range of the OPO is from 1120 nm to 1200 nm, no 
significant fluctuation of power was observed either before the HWP or at the specimen. Figure 
4.7 shows the mean pulse width of the laser beam before it enters the microscope. 
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Figure 4.5: Power level measured at the output of the OPO between PG1 and HWP - taken from 
(Vadakkan, Culver et al. 2009). 
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Figure 4.6: Attenuated power at the specimen measured using a power meter (S212A, Thermopile Sensor, 
Thorlabs) - taken from (Vadakkan, Culver et al. 2009). The power was measured using an IR-improved 
prototype objective lens from Carl Zeiss (32x/0.85 NA W). 
Wavelength (nm) 
Figure 4.7: The mean pulse width of the laser beam before it entered the scan head of the LSM using a 
Carpe autocorrelator - taken from (Vadakkan, Culver et al. 2009). Pulse widths at different average powers 
(20 mW for the solid line and 27 mW for the dotted line) were measured. The changes in the pulse width in 
the range from 1120 nm to 1150 nm and from 1150 nm to 1190 nm were both less than 100 fs. 
4.4.3. Ex vivo Imaging of Nanoshells 
Figure 4.8 shows the images from the veins in quadriceps muscle of a one-week-old mCherry 
neonate after injection of nanoshells. In these images, both nanoshells and mCherry were excited 
with the same 1140 nm laser. Two detection channels, one with a 520 nm-560 nm and the other 
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one with a 575 nm-640 nm band pass filter, were used to collect the emission. The nanoshells 
showed emission in both channels, while mCherry was observed only in the 575 nm-640 nm 
channel. All nanoshells were observed within mCherry-labeled vessels, supporting the hypothesis 
that nanoshells can be tuned for vessel imaging using an OPO as the excitation source. 
Accumulated nanoparticles (yellow arrows) were also observed, which may have been caused by 
the cessation of flow and deposition of particles at bifurcations after the mouse had expired. 
Figure 4.8: Ex vivo imaging of nanoshells at quadriceps muscles using a 1140 nm laser generated by an 
OPO. Nanoshells have a broader emission in both 520 nm-560 nm and 575-640 channels, while vessels 
with mCherry have emission only in the 575 nm-640 nm channel. Bright nanoparticles (white arrow) were 
observed within the mCherry-labeled vasculature. Accumulated nanoparticles (yellow arrows) were also 
observed, which may be caused by the cessation of flow and deposition of particles at bifurcations after the 
mouse had expired. 
To further analyze the emission pattern of these nanoshells, four band pass detection 
channels, ranging from 380-640 nm were used. Figure 4.10 shows that the nanoshells have a 
broad emission ranging from 380-640 nm, which is similar to the spectral result using nanoshells 
tuned for an ordinary Titanium: Sapphire laser as discussed in Chapter 3. 
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Figure 4.9: Ex vivo imaging of nanoshells using a filter setting from 350-640 nm. Bright nanoparticles 
(white arrow) were observed in all four channels, indicating that nanoshells have a broad emission ranging 
from 380-640 nm. (A) (B) (C) (D) represent images from different band pass filters. (E) is the merged 
image of (A) to (D). 
4.4.4. Discussion: 
This chapter describes the development of a new kind of luminescent gold-silica nanoshells tuned 
for an OPO system, which produces micrometer-level wavelength lasers beyond the working 
range of an ordinary two-photon Titanium: Sapphire laser. Longer-wavelength NIR lasers 
generated from the OPO would be highly attractive by reason of their capacity to excite red 
fluorophores at their excitation peak and to extend imaging depth of live animal imaging. By 
tuning the core-shell ratio of the nanoshells, a new kind of gold-silica nanoshells was engineered 
with the peak of extinction at 910 nm, which is near the 1140 nm excitation wavelength. A 
transgenic animal model was used to produce a marker for the vasculature, which expresses 
mCherry fluorescent proteins in the vascular endothelial cells. A custom-built OPO system was 
used to produce 1 |am wavelength lasers and to excite both nanoshells and mCherry. In the animal 
imaging experiment, bright nanoparticles were observed within the mCherry-labeled vasculature, 
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and the emission of the nanoshells was shown to span a broad wavelength range (Figure 4.9), 
exhibiting a similar emission pattern as the nanoshells developed for the sub-fim wavelength 
Titanium: Sapphire laser. 
On the other hand, the ex vivo experiment revealed evidence of some accumulated 
nanoparticles (Figure 4.8), which may have resulted from the cessation of flow and deposition of 
particles at bifurcations after the mouse had expired. mCherry is a good vessel marker and is 
excitable with the OPO laser, but it becomes much dimmer in adult mice, and adult mice could be 
a better model for in vivo imaging owing to their longer survival time than the new born. The 
neonates used in these experiments died shortly after tail vein injection and local surgery, which 
is why imaging with the OPO has been limited to the ex vivo level. In order to image nanoshells 
in vivo using the OPO laser, adult mouse model is likely needed. Other red contrast agents 
excitable with the OPO could be utilized as substitute vessel co-markers to replace mCherry. In 
addition, the nanoshells used in this chapter have a peak of extinction at 910 nm, which is close to 
but not at the 1140 nm excitation wavelength. Other nanoshells with closer peaks of extinction to 
the excitation wavelength could have higher excitation cross sections and thus provide brighter 
signal as well as better contrast in future experiments. 
One important aim using the OPO is to improve the imaging depth of the two-photon 
excitation technique. Although extended imaging depth has been reported by using an OPO over 
a Titanium: Sapphire laser (Andresen, Alexander et al. 2009), little depth improvement was 
observed in this study. The reason is that the useful imaging depth that can be achieved with a 
confocal microscope is limited by poor axial resolution due to aberrations induced by the local 
changes in the refractive index of the tissue, caused by cell membranes and fat deposits (Booth, 
Neil et al. 2002; Schwertner, Booth et al. 2004). In two-photon microscopy, the aberrations result 
in reduction of laser power at the focal plane, thus losing emission signal. Therefore, even though 
at 1140 nm, we do not anticipate a significant improvement in the imaging depth compared to 
imaging at 750 nm. OPO with adaptive optics, which correct aberrations induced by the tissue, 
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could be used in two-photon microscopes to compensate for the aberrations and to improve the 
imaging depth (Marsh, Burns et al. 2003). 
4.5. Conclusions 
The experimental results indicate that gold-silica nanoshells may be used as luminescent contrast 
agents for vessel imaging using longer NIR light. Bright nanoparticles with a broad luminescent 
emission are resolved in the blood vessels ex vivo. This result suggests that gold-silica nanoshells 
may be further refined providing a new class of bright contrast agents for NIR luminescent 
imaging using an above 1 |im wavelength laser. 
74 
5. Conclusions and Future Directions 
5.1. Introduction 
Nanotechnology is offering revolutionary changes aimed at improving health care and advancing 
biomedical research. Materials gain special properties when their dimension is reduced to the 
nanometer scale, providing new approaches for disease diagnosis and treatment. In this thesis, the 
luminescence of gold-silica nanoshells has been studied for tissue imaging using two-photon 
microsocopy. The reason for selecting gold-silica nanoshells as the subject of interest is that their 
plasmon resonance can be tuned from visible into the NIR region, where the major fluorophores 
in the tissue have low absorption (Boulnois 1986; Weissleder 2001). The low choromphoric 
absorption and luminescent emission in the NIR spectrum are important in the context of optical 
imaging and diagnostics, principally because the optical interferences of intrinsic chromophores 
are suppressed when imaging is conducted in this region. Therefore, the excitation light can have 
deeper penetration in tissue with reduced phototoxicity (Lichtman and Conchello 2005). 
Because of their large extinction cross-section and strong absorptivity of light in the NIR 
region, nanoshells have been used in various biomedical applications, including photothermal-
controlled drug delivery systems (Sershen, Westcott et al. 2000), in vivo cancer therapy (Hirsch, 
Stafford et al. 2003), antibody-targeted photothermal ablation (Gobin, Moon et al. 2008), and 
optical contrast agents for combined imaging and photothermal ablation of cancer cells (Loo, 
Lowery et al. 2005; Gobin, Lee et al. 2007; Bickford, Sun et al. 2008). For the same reason, 
nanoshells are a potential candidate as an excellent luminescent contrast agent. Their 
luminescence has been shown to be much greater than that of typical dye-based fluorophores, 
such as fluorescent microspheres (Park, Estrada et al. 2008). In this thesis, the luminescence 
properties of gold-silica nanoshells have been further studied. Two specifically engineered 
nanoshells are used to generate luminescence in tissue when excited by either a sub-(im laser or 
an above 1 (im wavelength laser. A two-photon imaging platform is used to image these particles 
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in animal models. The engineering and characterization process of these nanoparticles are 
described in Chapter 3 and Chapter 4. 
5.2. Near Infrared Nanoshells for Luminescence Imaging 
Since gold nanoshells present attractive properties as potential contrast agents, the studies in this 
thesis aimed at developing a high-resolution imaging strategy to optically characterize nanoshells, 
and to evaluate their efficacy as NIR luminescent contrast agents. To serve this purpose, a two-
photon microscope was utilized as a high-resolution NIR imaging platform. Gold nanoshells were 
first engineered for excitation using a Titanium: Sapphire laser, which produces sub-jim 
wavelengths. Nanoshells were tested both ex vivo and in vivo. The luminescence spectra of these 
nanoshells showed a peak of emission in the red region of the visible range. Single particles 
flowing through the blood vessels were identified in live animals. Their brightness was 
demonstrated to be about 3 times higher than the dye-based fluorophores used as a baseline for 
comparison. Using a reconstruction algorithm for time lapse images of blood flow, the blood 
vessels were reconstructed from the images. These results indicate that gold nanoshells can be 
used as luminescent contrast agents for live animal imaging, and their bright luminescence can be 
further exploited to extend the imaging depth of NIR imaging techniques. 
To further explore the potentials of gold nanoshells as luminescent contrast agents, an 
additional kind of gold-silica nanoshells was developed for excitation with a micrometer-level 
laser in Chapter 4. Longer-wavelength light undergoes less scattering in the tissue and, can thus 
potentially extend the imaging depth. As bright contrast agents with the peak of emission in the 
red region of the visible spectrum, nanoshells are promising candidates for development as 
contrast agents using micrometer-level NIR excitation. This micrometer-level NIR laser was 
generated by an OPO pumped by a Titanium:Sapphire laser. The imaging system was first 
calibrated to ensure stable output. A transgenic mouse line was used as an animal model for 
nanoshell imaging. The mouse line expressed mCherry fluorescent proteins in the vascular 
endothelial cells, and it was used as a co-label marker for the vasculature. Nanoshells 
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demonstrated marked contrast when imaged in the mCherry-labeled vessels after intravenous 
injection. The results demonstrated the superior luminescent properties of gold-silica nanoshells 
as tunable contrast agents excitable with both sub-(xm and micrometer-level wavelength lasers, 
potentially extending the imaging depth for high-resolution NIR imaging. 
5.3. Future Directions 
In the present study even though the nanoshells were imaged flowing within the vessels, they did 
not densely fill the vessels as we had anticipated. This impaired the contrast of the vessels 
imaged using the luminescence from the nanoshells. We tried to improve the contrast by 
increasing the concentration of the nanoshells injected into the animals. However, this led to 
disruption of vessels possibly due to heating of nanoshells. As discussed in Chapter 3, using 
targeted nanoshells and time series images seem to be effective approaches. More specifically, 
nanoshells can be targeted by surface coating of antibodies or polymers to target the tissue of 
interest, such as vessels or tissue cells. This technique selectively accumulates nanoshells around 
the region of interest in order to achieve the needed level of contrast between the target and the 
background. At the same time, with an increased population of nanoshells specifically labeling 
the region of interest, the required laser power is consequently reduced, and the chance of 
photothermal damage during an imaging session is therefore minimized. For deeper tissue 
imaging, combining a longer imaging acquisition time with the reconstruction of the time series 
images is a good choice to enhance the contrast and the signal-to-noise ratio. 
While the two-photon imaging platform is capable of providing sub-micron resolution, 
the imaging depth is still limited to 1 (am. Since nanoshells possess both scattering and 
luminescence properties, it is possible to engineer nanoshells for dual-modality imaging. One 
possible application is combined OCT and two-photon imaging applications. OCT utilizes 
scattering from nanoshells to provide optical contrast with micrometer resolution and millimeter 
imaging depth. It can be used to locate the region of interest. Two-photon microscopy can then be 
used to provide more subtle images with sub-fim resolution, but reduced imaging depth using the 
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luminescence property of the particles. This imaging approach can be further combined with 
therapy. After the imaging, photothermal therapy can be executed with the same type of 
nanoshells, eliminating the cost and time of administering additional types of therapeutic agents. 
Using NIR imaging platform we have shown that it is possible to conduct in vivo imaging 
based on the luminescence from single nanoshells. This allows the possibility of using nanoshells 
conjugated with molecular targeted agents to detect the presence, relative abundance, distribution, 
and even transportation of the bio-molecules in their micro environment. In particular, size is an 
important consideration for nanoshells used as probes and tracers. Smaller probes are always 
preferred since they intervene with the functions of the targeted molecule to a lesser degree 
(Howarth, Liu et al. 2008; Liu, Howarth et al. 2008). 
This thesis is a critical advancement for in vivo imaging based on single particle 
luminescence from nanoshells excited with NIR lasers. We anticipate the single particle imaging 
approach will extend the imaging depth for high resolution NIR imaging techniques. 
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